Pioneering Biologics Safety and Manufacturing Efficiency
Updated event information for the 24TH Planova™ Workshop
The information about The 24TH Planova™ Workshop has been updated.
Please check the PDF file below for the 2nd announcement.
Register to attend The 24th Planova Workshop： https://asahiws2023.vfairs.com/
Save the Date: The 24th Planova™ Workshop will take place on November 16 and 17, 2023
asahi Kasei Bioprocess Europe is pleased to announce that the 24th Planova™ Workshop will be held in the beautiful city of Florence.
Program, venue, registration, and accommodation details will be informed in our next announcement on our workshop page.
The 24th Planova™ Workshop
Further to our announcement in January, we are pleased to send you more information on:
The 24TH Planova™ Workshop
Planova™ Seminar 2023 Turkey
Hyatt Centric Levent Istanbul
Istanbul, Turkey
PLaNOVa S20N Webinar for Biopharmaceuticals
"Ready for any Challenges" - New Planova™ S20N, its next-generation regenerated cellulose virus filter, was developed to offer unique solutions to the challenges in the manufacturing processes of your molecules -- reducing time and cost while allowing to assure a robust viral safety margin.
You are cordially invited to the webinar commemorating the launch of Planova S20N. In this webinar, you will learn how Planova S20N was designed to contribute to efficiently produce medicines that patients can trust. Jessica Waller, Principal Scientist, Biologics Development, Bristol Meyers Squibb, also joins us to discuss BMS' unique experience with Planova S20N.
Date: March 1, 2023
Planova™ S20N Virus Removal Filters
planovaS20_1.jpg
planovaS20_2.jpg
Details for Planova™ S20N
Integrity Test Procedure for Planova™ S20N Filters - Visual Leakage Test -
Product Specification Sheet for Planova™ S20N Virus Removal Filters
http://engconf.us/conferences/biotechnology/integrated-continuous-biomanufacturing-v/
Barcelona, Spain
PPTa 2022 Plasma Protein Forum
https://www.pptaglobal.org/meetings-events/plasma-protein-forum/overview
Washington, D.C. USa
The 12th Plasma Product Biotechnology Meeting
https://plasmaproductmeetings.com/
Limassol, Cyprus
BioProduction congress part of CPHI
https://informaconnect.com/bioproduction/
Frankfurt, Germany
BPI Viral Vectors Digital Week
https://ms.informaengage.com/ViralVectorDigitalWeek2022?partnerref=BPIDWEventsPage&_ga=2.241417029.655379500.1665125508-1761532142.1617009255
Virtual
BioProcess International Fall Digital Week
https://informaconnect.com/bioprocess-international-events/bioprocess-international-digital-weeks/
Virtual
USP/BioPhorum Joint Workshop on Continuous Manufacturing of Biologics
https://www.usp.org/events-training/usp-biophorum-joint-workshop-on-continuous-manufacturing-of-biologics
Rockville, MD, USa
7th DIa Cell and Gene Therapy Products Symposium in Japan
https://www.diaglobal.org/en/conference-listing/meetings/2022/12/7th-dia-cell-and-gene-therapy-products-symposium-in-japan
Hybrid, Tokyo, Japan
The 22nd China Biological Products annual Conference (CBioPC)
https://my.cbiopc.cn/pc/page/1dab0000-1398-f20b-6e02-08d9a8189f09
Zhuhai, China
The 13th Conference of the aseanian Membrane Society
https://www.ams13.org/#:~:text=It%20is%20a%20great%20honor,on%204%20%E2%80%93%206%20July%202022
Hybrid, Singapore
aCS Recovery of Biological Products XIX Conference
Rome, Italy
https://www.recoveryconferences.org/index.php?top=home
24th Interphex Week Tokyo PharmaLab Expo 2022
Tokyo, Japan
https://www.interphex.jp/en-gb.html
https://www.achema.de/en/
Frankfurt, Germany
Jiangsu, China
http://ebc.ienmore.com/english.html
https://www.bmapglobal.com/bioconexpo2022
Hangzhou, China
https://biotalk.eu/
Berlin, Germany
ViruSure 2nd Virus Safety Workshop
https://virusure.com/about-us/upcoming-events/virusure-virus-safety-workshop/?register=VirusSafety-Workshop
Vienna, austria
https://informaconnect.com/bioprocessinternational/
Hybrid, Boston, Ma, USa
Integrity Test Procedure: Planova™ 15N, 20N, 35N and 75N Filters Visual Leakage Test (VLT)
Validation Report: asahi Integrity Test Solution Kit: aGP-Ha35
Validation Report: asahi Integrity Test Solution Kit: aGP-Ha20
Validation Report: asahi Integrity Test Solution Kit: aGP-Ha15
Filtration Procedure: Planova™ 15N, 20N, 35N and 75N Filters
Integrity Test Procedure: Planova™ 15N, 20N and 35N Filters: Liquid Forward-Flow Rate (LFR) Test
planovaS20_2.jpg
planovaS20_3.jpg
planovaS20_4.jpg
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 23rd Planova™ Workshop
The 23rd Planova™ Workshop was successfully held from October 6 to October 7, 2022. In this 23rd Planova Workshop, we were honored to have many insightful and interesting presentations followed by great discussions.
Updated event information for the 23rd Planova™ Workshop
The 23rd Planova™ Workshop was successfully held from October 6 to October 7, 2022. The biographies and abstracts of the speakers and presentation slides made available by the speakers can now be downloaded on the Events Page.
Our website is scheduled server maintenance
asahi Kasei Medical Co., Ltd.
Our website is scheduled server maintenance for the following date and time:
Date: October 26, 2022
Our website is scheduled server maintenance
asahi Kasei Medical Co., Ltd.
Our website is scheduled server maintenance for the following date and time:
Date: October 26, 2022
Novel Planova™ Filter - Planova S20N
Kazuya Kobayashi
Manager, Global Sales & Customer Services Department
asahi Kasei Medical
Reliable experts in ensuring your product safety
We care about our product safety and quality the most, ilke you do. Our Planova™ virus removal filters and asahi Kasei Bioprocess team have been the trusted resources for decades in ensuring the viral safety of various biopharmaceutical products, and we have worked closely with various regulatory bodies in developing together the science and technology to ensure safe biologics for patients. Explore this page to find out how our products and in-depth support can help you ensure the safety of your products.
We provide technical and regulatory expertise to ensure the viral safety of your biologics. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Full support for a long-term manufacturing success
asahi Kasei Bioprocess is aspired to provide a long-term and in-depth support to our customers during the commercial manufacturing phase. We foresee the possibility of "unseen" costs and unexpected troubles in biopharmaceutical manufacturing, and to assist you with these, we provide in-depth consultation on our product usage and installation, we respond quickly for troubleshooting, we provide complimentary on-site and off-site trainings to operators, and we continuously improve on the usability of our products, both consumables and equipment.
Explore products, technical supports and trainings to help you achieve a long-term success in your downstream biopharmaceutical manufacturing. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Total support for a consistent success
We understand that a successful and smooth technology transfer is crucial to ensure a long-term success of biopharmaceutical manufacturing process, and asahi Kasei Bioprocess is a partner that you can absolutely count on to ensure this. Not only are our products reliable in providing scalable and consistent performance to help you speed up your technology transfer, our technical support team provides a full support to ensure a timely and successful transfer of technology. Explore this page to find out how you can increase your competitiveness with consistent and reliable virus filtration and downstream bioprocessing technology.
Explore products and support services that ensure a smooth and successful technology transfer of your downstream bioprocessing. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Reliable team of experts for a more optimized bioprocessing
To support the development of a more efficient process for your virus filtration and downstream bioprocessing, asahi Kasei Bioprocess' virus removal filters and bioprocess consumables are designed to be equipped with both excellent reliability and consistent performace. Furthermore, our team of experts is always motivated to work together with you to achieve a more optimized process results. Explore this page to learn more about performances of our products and ranges of support available for your development projects.
Explore products and support services to help advance and optimize your R&D and Process Development. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Your collaborator in achieveing viral-safe culture media
Biological product safety is not only achieved through downstream processing. asahi Kasei Bioprocess would like to be your partner in ensuring the viral safety of your culture media for bioprocessing, using our advanced virus filtration technology, as well as in-depth technical support.
Explore solutions to ensure the viral safety of your cell culture media. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
The evolving yet reliable partner for your novel proteins
asahi Kasei Bioprocess continuously strives to innovate together with our customers in meeting the needs associated with the technological advances in recombinant protein developmnent. We offer various products and services to help you advance your process development and manufacturing for various recombinant proteins. Explore this page to find out how we can work together to overcome the challenges to ensure product safety and manufacturing efficiency of your recombinant protein products.
Explore resources to help you achieve safe and efficient downstream bioprocessing for your novel recombinant proteins. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Your partner in virus filtration and downstream process optimization for mabs
Leveraging our extended experience in bioprocess, asahi Kasei Bioprocess aims to be your dependable partner in ensuring your product safety and manufacturing process efficiency. For example, Planova™ BioEX virus removal filters have been shown to work effectively for various monoclonal antibodies, even those considered difficult to filter, thus serving as a reliable virus filtartion solution for your dowstream bioprocessing. Explore this page to find out how we can work together to achieve a more efficient process that produces safer monoclonal antibodies.
Explore resources to help you achieve safe and efficient downstream bioprocessing for monoclonal antibodies, even the difficult ones. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
The pioneer in virus filtration for plasma-derived products
Since 1989, Planova™ virus removal filters have been trusted by various pharmaceutical companies in ensuring viral safety of their plasma-derived products, such as immunoglobulins, coagulation factors, alpha-1-antitrypsin, c1inhibitors, and many others. Explore this page to find resources that may help you in improving the safety and efficiency of your plasma-derived product manufacturing processes.
Explore resources to help you improve the viral safety and efficiency of your plasma-derived product manufacturing processes. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch in October of Planova™ S20N, its next generation regenerated cellulose virus filter that's ready for any challenges. S20N promises "superior" filtration performance for various types of biopharmaceutical products, "secure" robust virus removal capability, and "simplified" operation for your post-use integrity test.
asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. asahi Kasei Medical aims to provide "assurance Beyond Expectation" in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, scientific support, and biosafety testing services to help biologics manufacturers safely and efficiently produce medicines that patients can trust.
By adding Planova™ S20N to its family of advanced virus removal filters, asahi Kasei Medical endeavors to contribute to further improvement of operations and the greater safety of biologicals and to further driving the growth of the healthcare sector of the asahi Kasei Group.
Updated event information for the 23rd Planova™ Workshop
The information about The 23rd Planova™ Workshop has been updated.
Please check the PDF file below for the 4th announcement.
Register to attend The 23rd Planova Workshop
Updated event information for the 23rd Planova™ Workshop
The information about The 23rd Planova™ Workshop has been updated.
Please check the PDF file below for the 3rd announcement.
Register to attend The 23rd Planova Workshop
Updated event information for the 23rd Planova™ Workshop
The information about The 23rd Planova™ Workshop has been updated.
Please check the PDF file below for the 2nd announcement.
Register to attend The 23rd Planova Workshop
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical Corporation is pleased to announce that research findings of the blocking model theory elucidated a more rigorous verification of the filtration behavior of "Planova™" virus removal filter.
asahi Kasei Medical is the global market leader in virus filtration, with its "Planova™" having an unrivaled 30-year history of trusted use in the production of biotherapeutics. We aim to provide "assurance Beyond Expectation" to ensure product safety and manufacturing efficiency for therapeutics within the biopharmaceutical industry in the form of innovative yet exceptionally reliable purification consumables, equipment and support services.
Relocation of asahi Kasei Bioprocess Office in Brussels
We wish to inform you that the asahi Kasei Bioprocess Europe office in Brussels address has relocated to new premises effective 1st June 2022; our new address is:
asahi Kasei Bioprocess Europe S.a./N.V.
Boulevard auguste Reyers 70
about asahi Kasei Bioprocess
Our Business OverviewOur Global NetworkOur History
Pioneering Biologics Safety and Manufacturing Efficiency
asahi Kasei Medical Completes acquisition of Bionova Scientific, U.S.-based biopharmaceutical CDMO
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical has completed its acquisition of Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies as announced on april 19, 2022. The acquisition closed on May 31, 2022 (US Pacific time).
Bionova Scientific will operate as a business unit within asahi Kasei Medical's Bioprocess Division, and Darren Head, the current CEO of Bionova Scientific, will continue to lead the company. Bionova Scientific will continue to expand its business by building on its strengths as a CDMO specialized in the process design and manufacture of various types of biologics that are particularly difficult to develop. Moving forward, asahi Kasei Medical aims to provide biopharmaceutical companies with further added value and higher customer satisfaction by leveraging its existing bioprocess consumables, equipment and biosafety testing services businesses together with Bionova Scientific's biologics CDMO business.
Updated event information for the 23rd Planova™ Workshop
The information about The 23rd Planova™ Workshop has been updated.
Please check the PDF file below for the 1st announcement.
The 23rd Planova Workshop 1st announcement.pdf
asahi Kasei Medical acquires U.S. based mycoplasma testing services provider Bionique
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical Co., Ltd. today announced that it has (via a wholly owned subsidiary) fully acquired Bionique Testing Laboratories LLC (Bionique), a leader in mycoplasma testing services for the biotherapeutics and life-sciences industries. The transaction was completed on December 15, 2021 (US Eastern Time).
Mycoplasmas are bacteria that are of particular concern in the manufacture of biotherapeutics (medicines composed of, or derived from, biological substances). This is because mycoplasmas are typically pathogenic, difficult to detect, and display natural resistance to antibiotics. Furthermore, contamination countermeasures are very difficult to implement. Therefore, mycoplasma testing services such as those offered by Bionique are critical to patient safety, as they enable the avoidance of mycoplasma contamination throughout a wide range of steps during the research, process development and manufacturing of biotherapeutics. Bionique is known for its unmatched expertise in mycoplasma testing, and has over 30 years of specialist experience in this field. Bionique is also gaining attention for its ability to provide validated GMP solutions to especially challenging issues faced when performing mycoplasma testing in connection with emerging and rapidly growing treatment modalities such as cell and gene therapy, and regenerative medicines.
asahi Kasei Bioprocess has launched its official LinkedIn and WeChat accounts
as part of our marketing activities, asahi Kasei Bioprocess opened new LinkedIn (English) and WeChat (Chinese) accounts.
By following these accounts, a range of timely information about the asahi Kasei Bioprocess, such as press releases and events, can be obtained.
asahi Kasei Medical aims to provide "assurance Beyond Expectation" in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, scientific support, and biosafety testing services to help biologics manufacturers safely and efficiently produce medicines that patients can trust.
asahi Kasei Medical to acquire Bionova Scientific, U.S.-based biopharmaceutical CDMO
asahi Kasei Medical Co., Ltd.
april 19, 2022
asahi Kasei Medical concluded an agreement on april 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies, especially those developing next-generation antibody based drugs*.
asahi Kasei Medical and JSR Enter Co-promotion agreement
asahi Kasei Medical Co., Ltd. (asahi Kasei Medical) is pleased to announce that asahi Kasei Medical and JSR Corporation (JSR) have entered into a co-promotion agreement for bioprocess products that will initiate sales collaborations in Europe and North america on april 1, 2022.
asahi Kasei Medical and JSR both supply key manufacturing technologies to the biopharmaceutical industry, with asahi Kasei Medical providing filters for virus filtration and cell harvesting/clarifications and JSR providing chromatography resin. Through this collaboration, the companies will each broaden their access to sales channels and strengthen the sales potential of their respective products.
"This collaboration will leverage leading-edge technologies and expertise that both companies already have underway," said Ken Shinomiya, director and head of the Bioprocess Division of asahi Kasei Medical. "This agility to customer-centric innovation is one of many actions that we do with an aim to provide "assurance Beyond Expectation" to our customers."
https://informaconnect.com/bpi-asia/
Virtual
(Free-to-attend Live Webinar Series)
Cell & Gene Therapy Manufacturing & Commercialization asia Digital Week
https://informaconnect.com/celltherapy-asia/?_ga=2.47117858.405639979.1643261453-1761532142.1617009255
Virtual
(Free-to-attend Live Webinar Series)
Cell & Gene Therapy Manufacturing Digital Week Webinar Series
https://informaconnect.com/bioprocess-international-events/bioprocess-international-digital-weeks/
Virtual
BioProcess International Europe
https://informaconnect.com/bpieurope/
Vienna, austria
Hybrid
https://www.bmapglobal.com/bioconexpo2022
Hangzhou, China
BioProcess International Spring Digital Week Webinar Series
https://informaconnect.com/bioprocess-international-events/bioprocess-international-digital-weeks/
Virtual
https://biotalk.us/
Boston, Ma, USa
https://www.pda.org/global-event-calendar/event-detail/2022-pda-virus-conference
Brussels, Belgium
2022 PDa advanced Therapy Medicinal Products Conference
https://www.pda.org/global-event-calendar/event-detail/2022-pda-advanced-therapy-medicinal-products-conference
Brussels, Belgium
https://www.bagevent.com/event/5418850
Shanghai
Jiangsu, China
http://ebc.ienmore.com/english.html
https://www.interphex.jp/ja-jp/about/bp.html
Tokyo
https://www.bagevent.com/event/5418850
Shanghai
Save the Date: The 23rd Planova™ Workshop will take place on October 6 and 7, 2022
We are excited to renew our plans to hold the 23rd Planova™ Workshop. With our sights on New York City, we look forward to sharing the latest developments from current Planova filter users and our global Planova Team.
Please mark your calendar and visit our website (www.ak-bio.com) for updates. Direct any questions to WS2022@ak-bio.com.
The Role of Nanofiltration in the Pathogen Safety of Biologicals: an Update
Inouye, M. and Burnouf, T.
M.I.: asahi Kasei Medical Co., Ltd., T.B.: Taipei Medical University
Current Nanoscience, 2019, 15, 1-10
asahi Kasei Medical to Build New assembly Plant for Planova™ Filters
asahi Kasei Medical Co., Ltd.
February 16, 2022
asahi Kasei Medical has decided to expand the production capacity of Planova™ filters by constructing a new assembly plant in Nobeoka, Miyazaki, Japan. The new plant will be designed to realize a smart factory by accelerating manufacturing automation and digital transformation in order to enhance quality and production efficiency. The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024.
Our website is scheduled server maintenance
February 7, 2022
asahi Kasei Medical Co., Ltd.
Our website is scheduled server maintenance for the following date and time:
February 2, 2022
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical Corporation is pleased to announce that research findings of the first-ever particle-based quantitative demonstration of the virus retention capacity of PlanovaTM virus removal filters elucidate the cause of inconsistency in virus filter performance for virus removal validation.
Review paper on filter made of cuprammonium regenerated cellulose for virus removal
January 26, 2022
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical Corporation is pleased to announce the review paper on the filter made of cuprammonium regenerated cellulose for virus removal has been published in the scientific journal Cellulose.
Save the Date: The 23rd Planova™ Workshop will take place on October 6 and 7, 2022
We are excited to renew our plans to hold the 23rd Planova™ Workshop. With our sights on New York City, we look forward to sharing the latest developments from current Planova filter users and our global Planova Team.
Please mark your calendar and visit our website (www.ak-bio.com) for updates. Direct any questions to WS2022@ak-bio.com.
Bioprocess International US West
https://informaconnect.com/bpi-west/
Hybrid San Diego, Ca, USa
aCS Spring 2022 National Meeting
https://www.acs.org/content/acs/en/meetings/acs-meetings/about/future-meetings.html
Hybrid San Diego, Ca, USa
Hybrid Barcelona, Spain
https://www.bioprocessingeurope.com/
asahi Kasei Medical Wins Europe Bioprocessing Excellence award for Viral Filtration Category
asahi Kasei Medical Co., Ltd. has received the Europe Bioprocessing Excellence awards 2021 for Viral Filtration. This recognition was for exceptional bioprocessing experts, organizations, and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost, and superior quality throughout the world, including Europe.
The award ceremony was held virtually during Biologics Contract Manufacturing Europe and Biologics World Nordic Virtual Conference. a panel of external judges includes key opinion leaders, industry professionals from all the key players in asia and globally.
asahi Kasei Medical dependably provides innovative yet exceptionally reliable bioprocess consumables, equipment and related scientific support, and biosafety testing services, to help biotherapeutics manufacturers safely and efficiently produce medicines that patients can trust.
Privacy policy
In the course of doing business, asahi Kasei Group receives personal information (the term "personal information" is used herein as defined in article 2, Paragraph 1, of the act on the Protection of Personal Information (act No. 57 of 2003)) such as names, postal addresses, phone numbers, and e-mail addresses from consumers, clients, suppliers, and others, in addition to the personal information of our executives and employees which we hold. We are committed to maintaining the privacy and security of this personal information, and to ensuring that it is handled appropriately in accordance with this policy.
Because this policy may be revised, we recommend that you refer to this page again from time to time.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 21st Planova™ Workshop
The 21st Planova™ Workshop
Updated event information for 2021 Planova™ EU Virtual Symposium
The 2021 Planova™ EU VIRTUaL SYMPOSIUM was successfully held from September 30 to October 1, 2021. The biographies of the presenters and presentation materials made available by the speakers are now available for download on the Seminars Page (you will need your user ID and password to download).
2021 PLaNOVa™ EU VIRTUaL SYMPOSIUM
The 2021 PLaNOVa™ EU VIRTUaL SYMPOSIUM was successfully held on September 30 to October 1, 2021. In this 2021 PLaNOVa™ EU VIRTUaL SYMPOSIUM, we were honored to have many insightful and interesting presentations followed by great discussions.
The biographies and abstracts of the speakers, as well as presentation slides made available by speakers can be downloaded at the end of this page (you will need to log in or register to view this content).
Fundamentals and Regulatory
Our website is scheduled server maintenance
asahi Kasei Medical Co., Ltd.
Our website is scheduled server maintenance for the following date and time:
Date: October 22, 2021
High applicability of Planova™ BioEX in the Continuous Process
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical and Manufacturing Technology association of Biologics have proved that Planova™ BioEX has high applicability in the mab continuous process.
asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. We aim to provide "assurance Beyond Expectation" to ensure product safety and manufacturing efficiency for therapeutics within the biopharmaceutical industry in the form of innovative yet exceptionally reliable bioprocess consumables, equipment and related scientific support, and biosafety testing services.
Our website is scheduled server maintenance
asahi Kasei Medical Co., Ltd.
Our website is scheduled server maintenance for the following date and time:
Date: October 15, 2021
Updated event information for 2021 Planova™ EU Virtual Symposium
The information about the 2021 Planova™ EU Virtual Symposium has been updated. Please check the PDF file below for the 5th announcement.
2021 PLaNOVa EU VIRTUaL SYMPOSIUM 4th announcement.pdf
Updated event information for 2021 Planova™ EU Virtual Symposium
The information about the 2021 Planova™ EU Virtual Symposium has been updated. Please check the PDF file below for the 5th announcement.
2021 PLaNOVa EU VIRTUaL SYMPOSIUM 5th announcement.pdf
https://planova.ak-bio.com/local-seminars/2412.php
Virtual
american Chemical Society (BIOT) annual meeting
https://www.acsbiot.org/index.php/meetings/2020-meetings-2/
Hybrid, atlanta, Ga, USa
2021 PDa BioManufacturing Conference
https://www.pda.org/global-event-calendar/event-detail/2021-pda-biomanufacturing-conference
Virtual
BIC 2021 BioPharma Innovation Conference
https://www.bagevent.com/event/7115782
Shanghai, China
Life Science Baltics/ Digital forum
https://lifesciencesbaltics.com/
Virtual
BioProcess International (BPI-East)
https://informaconnect.com/bioprocessinternational/
Hybrid, Boston, Ma, USa
antibody-based Therapeutics & BioProduction Forum (aTBP)
Shanghai, China
4th Edition Biologics Manufacturing Nordics 2021
Virtual
Nanjing, China
https://informaconnect.com/bioproduction/
Milan, Italy
https://pharmtech-expo.ru/Home
Moscow, Russia
BPI Cell & Gene Therapy Manufacturing & Commercialization Europe
https://informaconnect.com/celltherapy/
Vienna, austria
https://www.interphex.jp/en-gb/about/exhibits/bp.html
Makuhari, Chiba, Japan
The Planova™ Seminar 2021 India was successfully held on February 12, 2021. In this Planova™ Seminar 2021 India, we were honored to have many insightful and interesting presentations followed by great discussions.
See the list of speakers and program of the Planova™ Seminar 2021 India in the following PDF document.
Program-at-glance_PLaNOVa SEMINaR 2021 INDIa.pdf
Updated event information for 2021 Planova™ EU Virtual Symposium
The information about the 2021 Planova™ EU Virtual Symposium has been updated. Please check the PDF file below for the 3rd announcement.
2021 PLaNOVa EU VIRTUaL SYMPOSIUM 3rd announcement.pdf
asahi Kasei Medical to Double Production Capacity for Planova™ BioEX Filters
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical has decided to expand production capacity of hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membranes for Planova™ BioEX filters at its spinning plant in Oita, Japan. The global COVID-19 pandemic has increased the urgent demand for Planova™ filters, which are indispensable to develop and mass-produce anti-coronavirus agents. asahi Kasei Medical will double spinning production capacity at this site by utilizing its state-of-the-art technology. The capacity increase is expected to commence in the fourth quarter of calendar year 2022.
as for the Planova™ N series filters made with cellulose hollow-fiber membranes, all six existing plants, including the spinning plant completed in 2019 in Miyazaki, Japan, have been operating efficiently and without any disruption to meet the increasing demand worldwide.
Hopefully, you and your families are healthy and safe during these uncertain and unprecedented times!
The COVID-19 pandemic has caused an immense change to our daily lives and it also continues to define our new normal. This is a challenge we must overcome together in cooperation and mutual
responsibility. Taking into account the health and safety of our customers and our staff, we recognized that organizing physical events is still too high of a risk.
Updated event details for 2021 Planova™ EU Virtual Symposium
Further to our 1st announcement in april, we are pleased to give you more information on the upcoming Planova™ EU Virtual Symposium. We are delighted to announce the Chairs of the Virtual Symposium: Dr. Thomas R. Kreil, Dr. Salvador Grancha, Dr. Uwe Gottschalk, and Dr. Nathan J. Roth.
It will be a superb opportunity to gain new insights and learn about the state-of-the-art technology that can improve your processes. In addition to the presentations, you will be able to visit the exhibition hall with different booths. Our virtual platform enables you to chat not only with our global Planova team members, but also with other Planova users and key industry leaders.
We look forward to receiving your registration!
asahi Kasei Medical Bioprocess affiliate Opens in China
asahi Kasei Medical Co., Ltd.
april 21, 2021
asahi Kasei Medical announces that an affiliated company in China, asahi Kasei Bioprocess (Shanghai) Co., Ltd. (aKBC), started business on april 1, 2021.
Save time and cost of conducting a direct audit by utilizing audit reports available from an international supply chain consortium. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
audit Reports availability
audit reports for Planova Plant and Planova Oita Plant are now available for purchase from Rx-360, an international pharmaceutical supply chain consortium.
January 27, 2021
asahi Kasei Medical Co., Ltd.
a research team at asahi Kasei Medical and Gakushuin University led by Prof. Takayuki Nishizaka of the Department of Physics has shown for the first-time direct visualization of the behavior of virus and proteins in Planova™ virus removal filters using an advanced microscope system with confocal optics.
Where do I find current job listings for asahi Kasei Bioprocess?
For jobs in Japan, our listings can be found via asahi Kasei Group Website as follows: http://www.asahi-kasei-jobs.com/ (In Japanese Language only; note that jobs specific to Bioprocess may not always be available)
For jobs in the USa, our listings can be found via asahi Kasei america Website as follows: https://akamerica.wd5.myworkdayjobs.com/en-US/aka (note that jobs specific to Bioprocess may not always be available)
For other regions, please contact us to inquire about job opportunities.
Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy
Jorquera, J. I.
Institute Grifols S.a.
Clinical and Experimental Immunology 157: 17-21
abstract Only
Diez, J. M., et al.
Instituto Grifols S. a.
abstract Only
Soluk, L., et al
Cangene Corporation and Baxter Healthcare Corporation
International Biopharma 4.0 Summit 2020
Shanghai
http://www.borscon.com/2020cibp4.0/en/index.html
Sitemap
Development Stage
Products & Services
The Planova™ Seminar 2020 Turkey was held as follows:
Planova™ Seminar 2020 Turkey
Virtual Event
2020 Planova™ US Virtual Symposium
Fundamentals and Regulatory
Biologist/Research Reviewer
FDa
Updated event details for 2020 Planova™ US Virtual Symposium
The 2020 Planova™ US VIRTUaL SYMPOSIUM was successfully held from September 30
The biographies of the presenters and presentation materials made available by the
speakers are now available for download on the Seminars Page (you will need your user
Updated event details for Planova™ Seminar 2020 Turkey
The Planova™ Seminar 2020 Turkey was successfully held on September 15, 2020.
The biographies of the presenters and presentation materials made available by the speakers are now available for download on the Seminars Page (you will need your user ID and password to download).
Responding to the spread of COVID-19: Weekly roundup September 25, 2020
The COVID-19 situation has evolved further across the world and induced unprecedented challenges for the global economy. We are expressing our condolences to those who have been directly affected by this pandemic. Our thoughts and prayers are with them for a speedy recovery of those impacted, and we hope that this pandemic will subside promptly for all nations.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners, and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. We have been posting our weekly roundup of responding to the spread of COVID-19 since april 1, 2020. We will stop posting the weekly roundup at the end of September and remain committed to providing timely updates via this website as necessary should the situation changes.
Responding to the spread of COVID-19: Weekly roundup September 18, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Updated event details for 2020 Planova™ US Virtual Symposium
The information about 2020 Planova™ US Virtual Symposium has been updated. Please refer to the following announcement for details.
2020 Planova US Virtual Symposium 2nd announcement.pdf
Responding to the spread of COVID-19: Weekly roundup September 11, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup September 4, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup august 28, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Planova™ BioEX Virus Removal Filters
Your First Choice Virus Filtration Partner that You Can absolutely Rely On
Planova™ BioEX - your first choice virus filtration partner that you can rely on. Explore the features of Planova™ BioEX filters and support services to make your virus filtration process more efficient. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
application
Scott Lute, Julie Kozaili, et al.
U.S. FDa, asahi Kasei Medical Co., Ltd.
Open
Planova™ 15N, 20N & 35N Virus Removal Filters
The Pioneer Virus Filter with Proven Reliability Since 1989
Planova™ 15N, 20N, 35N Virus Removal Filter - The Pioneer Virus Filter with Proven Reliability Since 1989. Explore the features of Planova™ 15N, 20N, 35N filters and support services to make your virus filtration process more efficient. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
applications
Responding to the spread of COVID-19: Weekly roundup august 21, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Product Specification Sheet for Planova™ BioEX Virus Removal Filters
abstract Only
Morrica, a., et al.
Kedrion S.p.a. and Q-ONE Biotech Ltd
Integrity Test Kit Sample Certificate of analysis (aGP-Ha35S)
Integrity Test Kit Sample Certificate of analysis (aGP-Ha35M)
Integrity Test Kit Sample Certificate of analysis (aGP-Ha20S)
Integrity Test Kit Sample Certificate of analysis (aGP-Ha20M)
Integrity Test Kit Sample Certificate of analysis (aGP-Ha15S)
Integrity Test Kit Sample Certificate of analysis (aGP-Ha15M)
Validation Report for Planova™ BioEX Filter Integrity Tests - Horizontal Visual Leakage Test -
Integrity Test Procedure for Planova™ BioEX Filters - Horizontal Visual Leakage Test -
Integrity Test Procedure for Planova™ BioEX Filters - Visual Leakage Test -
aGP-Ha asahi Integrity Test Solution Kit Instructions for Use
Product Specification Sheet for Planova™ Virus Removal Filters
about Us
about asahi Kasei Bioprocess
about asahi Kasei Group
We are pleased to invite you to join the upcoming Planova™ Virtual Symposium.
In lieu of our usual Planova event, a virtual symposium will enable us to evolve safely to meet current COVID-19 challenges.
The theme of the Planova Virtual Symposium is "challenging processes". This theme includes, among others, the following topics: continuous processing, challenging molecules and process conditions.
Responding to the spread of COVID-19: Weekly roundup august 7, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup July 31, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup July 17, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup July 10, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Cell Therapy Manufacturing & Gene Therapy Congress
https://informaconnect.com/celltherapy/
amsterdam, The Netherlands
CBioPC The 20th China Biological Products annual Conferene
https://www.bio-equip.com/news.asp?ID=453082258
Zhuhai
https://informaconnect.com/tides-europe/
Vienna, austria
https://www.pharmtech-expo.ru/Home
Moscow, Russia
https://informaconnect.com/bioproduction/
Milan, Italy
https://www.imapac.com/en/business_conferences/biologics-world-nordic/
Virus Safety and Planova Nanofiltration
Copenhagen Denmark
https://www.pda.org/global-event-calendar/event-detail/biomanufacturing-conference
Dublin, Irland
https://lifesciencesbaltics.com/
Vilnius, Lithuania
https://informaconnect.com/bioprocessinternational/
Minimizing Resources in Developing Commercial Virus Filtration Processes with Planova™ BioEX"
Boston, Ma USa
The 2nd asia Biopharma Continuous Manufacturing & Process Innovation Conference
https://www.bagevent.com/event/5520024?bag_track=bagevent
Presentation
Shanghai China
american Chemical Society Fall 2020 National Meeting & Expo
https://www.acs.org/content/acs/en/meetings/national-meeting/abstract-submission.html
1. Evaluating Effects of Pressure Fluctuations by Constant Flow Method on Viral Clearance
2. Low Flux Impacts on Virus Filtration: The Devil is in the Details (Temporary)
https://informaconnect.com/bpi-west/
Minimizing Resources in Developing Commercial Virus Filtration Processes with Planova™ BioEX
aug 11, 11:00am
Talk "Minimizing Resources in Developing Commercial Virus Filtration Processes with Planova™ BioEX"
https://www.bioprocessingeurope.com/purification
a Virtual Event
https://informaconnect.com/bpieurope/
Talk 1. From "Batch Mode" to "Continuous" Bioprocessing: How the Virus Filter Fits In
https://informaconnect.com/bpieurope/speakers/jeroen-mangelschots/
https://www.bagevent.com/event/6298272?bag_track=lifeomics
Shanghai China
Responding to the spread of COVID-19: Weekly roundup July 3, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup June 26, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup June 19, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup June 12, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup June 5, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup May 29, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup May 22, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup May 15, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Learn about our training services for our Virus Removal solutions. Explore various on-site and off-site training services tailored to your operational needs. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Virus Filtration Trainings
Practice makes perfect; a trouble-free operation can be realized through effective trainings. While processes can be well defined in SOPs, human variability remains a critical factor. Training courses would help participants in clearing doubts, deepen understanding and reinforce techniques for practical application during operations. Our trainings cover both lab-scale and manufacturing-scale, aimed at improving the efficiency of filtration operations during both developmental and manufacturing phases. asahi Kasei Bioprocess virus filtration experts are always motivated to work together with customers to achieve operational success.
adan-Kubo, J., et al.
Japanese Blood Products Organization, asahi Kasei Medical Co., Ltd.
Open
Yue, C., et al.
Paul-Ehrlich-Institut, asahi Kasei, Instituto Oswaldo Cruz
Viruses. 2019 Mar; 11(3): 234.
Removal of small non-enveloped viruses by nanofiltration
abstract Only
Yokoyama, T., et al.
Japanese Red Cross and Sapporo Medical University School of Medicine & Department of Microbiology
Responding to the spread of COVID-19: Weekly roundup May 8, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup May 1, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
The 23rd Planova™ Workshop will be held in New York on October 1-2, 2020
We are pleased to invite you to attend the upcoming Planova™ Workshop.
The 23rd Planova™ Workshop
Crowne Plaza Times Square Manhattan
Responding to the spread of COVID-19: Weekly roundup april 24, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup april 17, 2020
We are expressing our condolences to those who have been directly affected by this pandemic. We sincerely wish for a full and speedy recovering for those still suffering of the COVID-19. We also pray for its speedy end and for the restoration of safety.
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to give sufficient consideration to infection prevention measures.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
Responding to the spread of COVID-19: Weekly roundup april 10, 2020
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to prevent the expansion of the COVID-19.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
•Measures to prevent the spread of COVID-19 (as of april 8, 2020)
Responding to the outbreak of the Coronavirus disease (COVID-19)
asahi Kasei Medical is committed to ensuring the safety and security of all our customers, partners and employees as our highest priority, establishing protocols and guidelines given by government authorities in order to prevent the expansion of the COVID-19.
The measures to prevent the spread of COVID-19 and the current status of production are as follows. The updated information will be posted on our website.
•Measures to prevent the spread of COVID-19 (as of april 1, 2020)
Planova™ BioEX Spotlight - Vol. 5 is Now Released
We are pleased to release Planova™ BioEX Spotlight Vol.5, the fifth release of our new periodical. This periodical introduces the features of Planova™ BioEX filters with a focus recent data. We welcome your feedbacks or request for additional information. Please feel free to contact us.
Planova_BioEX_Spotlight_vol.5.pdf
What are the sizes available for your products?
Information related to sizes can be found on Ordering Information Section of each product page, as follows:
- Planova™ BioEX filters
- Planova™ 15N, 20N and 35N filters
I would like to request samples of your products.
Please feel free to contact us with your request, quoting the Catalog Number of
the product(s) of interest. Catalog Numbers of each product can be found on its respective Ordering Information Section of each product page:
- Planova™ BioEX filters
Withdrawing from asiaTIDES and BioProcess International asia due to coronavirus risk
asahi Kasei Medical has made the difficult decision to withdraw from exhibiting and participating in asiaTIDES and BioProcess International asia scheduled between February 24th and 28th in Kyoto, Japan due to ongoing concerns about the recent outbreak of COVID-19 (commonly referred to as Coronavirus).The health and safety of all our customers, partners and employees are our top priority and we strongly believe this is the best course of action given the current circumstances.
We apologize for any inconveniences. We ask for your cooperation and understanding concerning this matter.
We extend our deepest sympathies with those directly impacted by this situation.
BioOptimal™ MF-SL Microfilters
Reduce bioburden quickly in clarification using BioOptimal™ MF-SL Hollow Membrane Fiber Microfilter, with speedy large volume processing capacity. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
applications
Process simplification
Planova™ Seminar 2020 Turkey will be held in Istanbul on april 8, 2020
asahi Kasei Bioprocess is pleased to announce the Planova Seminar 2020 Turkey, to be held on the following date:
Planova™ Seminar 2020 Turkey
Park Dedeman Levent Hotel
Save the Date: The 23rd Planova™ Workshop will take place on October 1 and 2, 2020
We are pleased to announce that the 23rd Planova Workshop will take place in New York City on the following dates:
Distinguished users of Planova and Planova BioEX filters will share their experiences and expertise in upstream and downstream process development. Regulatory authorities will present the latest developments. It will be an excellent opportunity to gain insights and to learn advanced techniques that can be applied to your processes.
For more detailed information regarding the agenda, venue, registration process and accommodations, please look for announcements posted on the Workshop Page.
asahi Kasei Medical acquires ViruSure
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical has acquired Virusure Forschung und Entwicklung GmbH (ViruSure), an austrian provider of biosafety testing services.
The acquisition is part of a strategic expansion and reinforcement of asahi Kasei Medical's bioprocess business, centered on Planova virus removal filters used in the manufacturing process for biotherapeutics such as plasma derivatives and biopharmaceuticals. It is indicative of asahi Kasei Medical's continuing strategic efforts to develop businesses that contribute to the safety of and efficient manufacture of biotherapeutics.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 22nd Planova™ Workshop
The 22nd Planova Workshop was held as follows:
Last call to join us in Lisbon!
We look forward to hosting you at the upcoming 22nd Planova™ Workshop in Lisbon where professionals from around the world will gather to share their expertise on topics such as virus filtration fundamentals, process development, robust manufacturing and new trends.
Confirmed chairs, speakers and tentative presentation titles are shown below.
Chairs
New spinning plant for Planova™ filters has been officially completed
asahi Kasei Medical Co., Ltd.
asahi Kasei Medical has completed the construction of a new plant for the spinning of cellulose hollow-fiber membranes for Planova virus removal filters in Nobeoka, Miyazaki, Japan.
Virus removal filters are used to enhance safety in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives. asahi Kasei Medical has earned wide recognition among customers around the world for the performance and reliability of its virus removal filters--both Planova cellulose membrane filters, which were launched in 1989 as the world's first filters developed specifically for removing viruses from biotherapeutic products, and Planova BioEX hydrophilic PVDF (polyvinylidene fluoride) membrane filters, which provide superior viral clearance in high protein concentration solutions.
Updated event details for The 22nd Planova™ Workshop
We look forward to hosting you at the upcoming 22nd Planova™ Workshop in Lisbon where professionals from around the world will gather to share their expertise on topics such as virus filtration fundamentals, process development, robust manufacturing and new trends.
Confirmed chairs, speakers and tentative presentation titles are shown below.
Chairs
Virus Filtration Technical Support Service
Learn about our technical support services for our Virus Removal solutions. Explore how you can rely to our experts to find solutions to your virus filtration needs. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
We build our reputation as a reliable company not only through our products, but also through the services that our virus filtration expert team delivers. as the pioneer of virus filtration technology, our team is always driven to apply technical expertise in maximizing the potential of our service offerings ranging from technical support and consultancy, regulatory support, and sharing of scientific knowledge. We would like our customer to rely on us in ensuring biologics safety and manufacturing efficiency, from lab-scale trials to commercial production.
Lab Scale
The Planova™ Seminar 2019, China was held as follows:
Zhejiang Xizi Hotel, Hangzhou
on april 11-12, 2019
Opening of a new training and support center in Chelmsford, Ma, USa
april 15, 2019
asahi Kasei Medical Co., Ltd.
asahi Kasei Bioprocess america ("aKBa") has recently opened its Massachusetts Training Center, a new 5000 sq. ft technical training and support center in Chelmsford, Massachusetts, for customer training and product collaborations in virus filtration, bioprocess and fluid management. The facility is co-located with ZOLL Medical at 271 Mill Road in Chelmsford, and features a 1000 sq. ft laboratory space for Planova™ Operator Courses (training courses for Planova virus filter operation), demonstrations and evaluations, as well space for classroom training.
test_about asahi Kasei Bioprocess
about asahi Kasei Bioprocess
Our Business OverviewOur Global NetworkOur History
Pioneering Biologics Safety and Manufacturing Efficiency
Planova™ BioEX Spotlight - Vol. 3 is Now Released
We are pleased to release Planova™ BioEX Spotlight Vol.3, the third release of our new periodical. This periodical introduces the features of Planova™ BioEX filters with a focus on recent data.
We welcome your feedbacks or request for additional information. Please feel free to contact us.
TaE31168E_BioEX Spotlight_vol3_En.pdf
Use of a noninfectious surrogate to predict minute virus of mice removal during nanofiltration
abstract Only
Cetlin, D., et al
L-53
BioProcess International asia 2019
Join us at BioProcess International asia 2019!
Visit us at asahi Kasei Bioprocess Booth #5
Don't miss our talk!
Save the Date: The 22nd Planova™ Workshop will take place on October 10 and 11, 2019
We are pleased to announce that the 22nd Planova Workshop will take place in Lisbon, Portugal on the following dates:
The 22nd Planova™ Workshop
October 10 and 11, 2019
BioProcess International US West 2019
Santa Clara, Ca, USa
Boston, Ma, USa
BioProcess International Europe 2019
Vienna, austria
New York, NY, USa
BioProcessing Summit Europe 2019
Lisbon, Purtugal
Planova™ Seminar 2019, China will be held in Hangzhou on april 11-12, 2019
asahi Kasei Bioprocess is pleased to announce the Planova Seminar 2019, China, to be held at the
Zhejiang Xizi Hotel, Hangzhou
on april 11-12, 2019.
Explore filters that match your virus removal needs for biopharmaceutical processes. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Generally, virus removal using a virus filter is based on size exclusion mechanism, which means that viruses larger than the mean pore size of the filter membrane are retained while target protein molecules that are smaller in size pass through to be recovered.
Planova™ filters are available in various pore sizes to match the virus removal needs of particular product applications, as outlined in the figure below.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 20th Planova™ Workshop
The 20th Planova™ Workshop was successfully held in Prague, Czech Republic on November 9 and 10, 2017. The Workshop was attended by more than 200 speakers and participants, where fruitful exchanges of knowledge and case studies on viral safety and virus filtration were made. Presentations by 15 distinguished speakers on Fundamental Knowledge, Process Development, Robust Manufacturing and New Trends were shared. Furthermore, as the year 2017 sees a double anniversary of Planova™ virus removal filters, where Planova™ Workshop was held for the 20th time and it marks the 30th anniversary of the start of the Planova™ business, a Keynote Presentation was presented by the inventor of virus removal filter, Seiichi Manabe.
The 21st Planova Workshop presentation materials are now available for download
The 21st Planova™ Workshop was successfully held in San Francisco, California, USa on October 11 and 12, 2018.
We were honored to have many insightful and interesting presentations followed by great discussions. Seventeen presentations by distinguished speakers on Virus Filtration Fundamentals, Process Development, and Robust Manufacturing and New Trends were shared.
The biographies of the presenters and presentation materials made available by the speakers are now available for download on the Workshop Page (you will need your user ID and password to download).
Challenges of implementing virus filtration in continuous manufacturing
Daniel Strauss, Ph.D., Principal Scientist Science and Technology
asahi Kasei Bioprocess america
San Francisco, Ca, USa
Kevin K. Okimura, Senior Manager Outsourced Manufacturing
Portola Pharmaceuticals
San Francisco, Ca, USa
Clearing the way for viral clearance
David Cetlin, Founder/C.E.O.
San Francisco, Ca, USa
21st Planova Workshop
Of future biotechnology options and the central role of nanofiltrarion
andreas Wieser, D (I FH), Senior Laboratory associate Global Pathogen Safety
San Francisco, Ca, USa
21st Planova Workshop
Meeting Planova and Selecting BioEX for Our Monoclonal antibody Manufacturing Process
Yumiko Masuda, Scientist Biologics Technology Research Laboratories Biologics Division
Daiichi Sankyo
San Francisco, Ca, USa
Challenges & Strategies for Viral Filtration
Matt (Mingjiang) Luo, Ph.D., Executive Director Downstream Process Development and Haikuan Liu, Ph.D., associate Director Downstream Process Development
Wuxi Biologics (Shanghai)
San Francisco, Ca, USa
Samuel Vollert, Process Development Scientist I Downstream Process Development
Patheon (Thermo Fisher Scientific)
San Francisco, Ca, USa
Clarification Impurities Impact Viral Filtration of a Therapeutic antibody
Ryan Zolyomi, Senior Development associate Isolation & Purification Biological Development
Bayer U.S.
San Francisco, Ca, USa
Takayuki Nishizaka, Ph.D., Professor, Department of Physics
Gakushuin University
San Francisco, Ca, USa
Different apparent Size of Parvoviruses determined by Virus Filtration
Thomas Nowak, Ph.D., Senior Manager Pathogen Safety
San Francisco, Ca, USa
21st Planova Workshop
Establishing a Virus Filter Design Space - Impact of Process Interruption on Parvovirus Retention
ashlee Smith, associate Scientist BioTherapeutics Development - aPI; Discovery, Product Development & Supply
Janssen Research & Development
San Francisco, Ca, USa
Overview of Challenges in Virus Filtration: Principles and applications
Tomoko Hongo-Hirasaki, Ph.D., Senior Scientist Evaluation and analysis in Virus Filtration Bioprocess Division
asahi Kasei Medical
San Francisco, Ca, USa
a Review of Virus Filter Performance
Horst Ruppach, Ph.D., Director, Viral Clearance and Virology Biologics Testing Solutions
Charles River Laboratories
San Francisco, Ca, USa
Update on European Regulations
Johannes Blümel, Ph.D., Head of Virus Safety Section Department of Virology
Paul-Ehrlich-Institut
San Francisco, Ca, USa
Pharmtech 2018
http://www.pharmtech-expo.ru/
Moscow, Russia
Launch of Planova™ BioEX Virus Filters for Biopharmaceutical Processing
asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on June 17 of Planova™ BioEX, its new generation of hollow fiber membrane virus filters. Planova™ BioEX filters are specifically designed to meet the urgent need in downstream biopharmaceutical processing for robust virus filters that not only enhance safety, but also have higher filtration capacities and shorter processing times, even under demanding filtration conditions such as high protein concentration and high filtration pressure.
Developed using asahi Kasei Medical's unique technology base in cellulose hollow fiber virus filters and polymer science, Planova™ BioEX filters incorporate a durable hydrophilic PVDF (polyvinylidene fluoride) hollow fiber membrane, enabling them to cope with the harsh processing conditions typical of state of the art biopharmaceutical manufacturing. Using Planova™ BioEX filters, it is now possible to safely and efficiently filter large volumes of high protein concentration solutions, which are typically problematic for traditional types of virus removal filters, particularly those with flat membranes.
The key features of Planova™ BioEX filters are as follows:
Dates & Location of the 14th Planova™ Workshop 2011
asahi Kasei Bioprocess Europe is pleased announce the 14th Planova™ Workshop will take place on the 9th and 10th of November 2011 in Cologne.
This workshop will contain presentations on viral filtration theory and practice as well as industry-based applications and results. It will be an excellent opportunity to learn valuable techniques and gain insight that can be applied to your efforts in the industry and your company.
Distinguished speakers from Planova™ and New Membrane Technology users with direct and high experience in use of virus removal filters, process scale-up and new membrane technology as applied to biological products will share their priceless knowledge and experience during this seminar.
Opening of Cologne Technical Center for interactive learning experience of bioprocess technologies
asahi Kasei Bioprocess Europe N.V./S.a. announces the opening of its new Cologne Technical Center in Germany. The Cologne Technical Center gives you the opportunity to learn more about Planova™ virus removal filters, QyuSpeedTM D membrane adsorbers, BioOptimal™ MF-SL microfilters and automated Planova™ and Bioprocess equipment.
omers support for their process development, filtration optimization, and non-GLP studies at the Col
In our showroom we demonstrate automated integrity test systems, filtration systems as well as an IBDTM inline buffer dilution systems and a dynamic axial compression columns.
Participation in exhibition/conference in Palm Springs, California
asahi Kasei Bioprocess, Inc. is pleased to announce its participation in the following exhibition/conference.
Event Name
PepTalk: The Protein Science Week
Participation in exhibition/conference in London, UK
asahi Kasei Bioprocess Europe N.V./S.a. is pleased to announce its participation in the following exhibition/conference.
Event Name
5th annual Bioinnovation Leaders Summit
The 16th Planova™ Workshop to be Held in Rome on 7 and 8 November, 2013
asahi Kasei Bioprocess Europe N.V./S.a. is pleased to announce that the 16th Planova™ Workshop will take place on the following dates and venue.
16th PLaNOVa™ WORKSHOP
Rome, Italy
Exibition report: Pharmatech 2013 in Moscow, Russia
Pharmatech 2013
Date
Location
The 18th Planova™ Workshop to be Held in athens.
We are pleased to announce that the 18th Planova™ Workshop will take place in athens, Greece on the following dates:
18th Planova™ WORKSHOP
October 22 and 23, 2015
The 4th announcement of The Planova™ Workshop athens, Greece on October, 2015.
We are pleased to announce that the 18th Planova™ Workshop will take place in athens, Greece on the following dates:
18th Planova™ WORKSHOP
October 22 and 23, 2015
Inactivation and removal of Zika virus during manufacture of plasma‐derived medicinal products
Blumel, J. et al
Paul-Ehrlich-Institut
Transfusion 2017 (57) 790-796
Dey, a., et al
International aIDS Vaccine Initiative, Department of Microbiology and Immunology, et al
Biotechnology and Bioengineering 2018 (115) 885–899
The 20th Planova™ Workshop will take place on November 9 and 10, 2017
We are pleased to announce that the 20th Planova™ Workshop will take place in Prague, Czech Republic on the following dates:
The 20th Planova™ Workshop
November 9 and 10, 2017
The second announcement of The 20th Planova™ Workshop on November 9 and 10, 2017
The 20th Planova™ Workshop
November 9 and 10, 2017
Intercontinental Hotel Prague
The Third announcement of the 20th Planova™ Workshop on Novemeber 9 and 10, 2017
We are pleased to announce that the 20th Planova™ Workshop will take place in Prague, Czech Republic on the following dates:
The 20th Planova™ Workshop
November 9 and 10, 2017
The Fourth announcement of the 20th Planova™ Workshop on November 9 and 10, 2017
We are pleased to announce that the 20th Planova™ Workshop will take place in Prague, Czech Republic on the following dates:
The 20th Planova™ Workshop
November 9 and 10, 2017
The Fifth announcement of the 20th Planova™ Workshop on November 9 and 10
We are pleased to announce that the 20th Planova™ Workshop will take place in Prague, Czech Republic on the following dates:
The 20th Planova™ Workshop
November 9 and 10, 2017
a New Periodical: Planova™ BioEX Spotlight - Vol. 1 is Now Released
We are pleased to release a new periodical titled Planova™ BioEX Spotlight. This periodical introduces the features of Planova™ BioEX filters with a focus on recent data.
We welcome your feedbacks or request for additional information. Please feel free to contact us.
Planova BioEX Spotlight Vol1.pdf
Planova™ BioEX Spotlight - Vol. 2 is Now Released
We are pleased to release Planova™ BioEX Spotlight Vol.2, the second release of our new periodical. This periodical introduces the features of Planova™ BioEX filters with a focus on recent data.
We welcome your feedbacks or request for additional information. Please feel free to contact us.
Planova BioEX Spotlight Vol2.pdf
Last call to join us in San Francisco!
We are excited to host the 21st Planova™ Workshop in San Francisco next week!
This event will be the largest Planova Workshop we have ever hosted in the US, with an astonishing number of registrations from the US, Europe and asia! Space is limited as we head into the final week of accepting registrations. Make your plans to join us today!
Chairs, speakers and final presentation titles are shown below. Their biographies and abstracts are available on The 21st Planova™ Workshop Page (login required to view biographies and abstracts).
Join us at BioProduction Congress on Oct 10 in Dublin!
Please join us at BioProduction Congress 2018 that will be held on October 8th to 10th, 2018 in Convention Centre Dublin, Ireland!
We will be exhibiting at Booth #13 and will be presenting as follows:
"What are the main features required for a virus filter in a continuous process?"
Please join us at BioProduction Congress 2018 that will be held on October 8th to 10th, 2018 in Convention Centre Dublin, Ireland!
We will be exhibiting at Booth #13 and will be presenting as follows:
"What are the main features required for a virus filter in a continuous process?"
aspects Impacting Virus Filter Selection for Cell Culture-Based Biomanufacturing Processes
Sven Schubert, Senior Process Manager, DSP Process Design / Validation, Rentschler Biopharma SE
Prague
20th Planova™ Workshop
Planova™ History in Technological Innovation Recognized in Virus Removal Filter
Seiichi Manabe, Head of a Technical adviser Office, Manabe Gijutsushi Jimusho
Prague
20th Planova™ Workshop
Challenges of Implementing Virus Filtration into Continuous Manufacturing
Daniel Strauss, Principal Scientist, R&D, asahi Kasei Bioprocess america
Prague
20th Planova™ Workshop
Upstream Virus Barriers: Why and How
andreas Wieser, Senior Laboratory associate Global Pathogen Safety, Shire
Prague
20th Planova™ Workshop
Downscaling a Manufacturing Process with Planova™ 20N Filters for Viral Clearance Study
Javier Castrillo, Downstream Technician / Downstream Scientist, Process Development, mabxience
Prague
20th Planova™ Workshop
Validation of Planova™ 20N as an alternative Virus Reduction Filter for a Commercial Product
Denis P. Twomey, Principal Scientist Pharmaceutical Development and Manufacturing Sciences, Janssen Sciences Ireland UC
Prague
20th Planova™ Workshop
Viral Filtration of a Therapeutic Monoclonal antibody: Impact of Clarification Impurities
Hendri Tjandra, Senior Staff Scientist, Drug Discovery - Biologics Development, Bayer
Prague
20th Planova™ Workshop
Evaluation of Pre-Filtration on BioEX Process Performance for Monoclonal antibodies
ashlee Smith, associate Scientist, aPI-Large Molecule, Janssen Research and Development
Prague
20th Planova™ Workshop
Impact of Prefilter and Operating Parameters on Virus Filter Performance
Sean O'Donnell, Principal Research Scientist, Virology and Purification Development, Eli Lilly and Company
Prague
20th Planova™ Workshop
Olaf Stamm, Senior Specialist, Biopharmaceutical Services, Charles River
Goa
1st Planova™ Workshop in India
Update on European Viral Safety Regulations
Johannes Blümel, Head of Virus Safety Section Department of Virology, Paul-Ehrlich-Institut
Prague
20th Planova™ Workshop
Understanding Planova™ Virus Filtration and Designing Robust Virus Filtration Processes
Tomoko Hongo-Hirasaki, Senior Scientist, Group Manager of Evaluation and analysis, asahi Kasei Medical
Prague
20th Planova™ Workshop
Differential Retention of Parvoviruses During Virus Filtration
Thomas Nowak, Senior Manager, Virus Safety Development R&D, CSL Behring
Prague
20th Planova™ Workshop
Introduction of a Nanofiltration Step in FVIII Purification Process
Filippo Mori, Senior Researcher, Research Department, Kedrion
Prague
20th Planova™ Workshop
The 3rd Planova™ Seminar in Moscow
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
We are pleased to announce that the 3rd Planova Seminar will take place in Moscow on the following date and at the following venue:
aQUaRIUM HOTEL Moscow (at the site of the Crocus City International Exhibition Complex)
Updated event details for The 21st Planova™ Workshop
We are excited to host the upcoming 21st Planova™ Workshop in San Francisco on October 11 and 12, 2018!
This year's theme is achieving successful virus filtration of challenging molecules. Our speakers are preparing presentations to share their experiences in virus filtration of molecules, including ones with challenging molecule properties, process conditions or process development considerations, so be sure to check them out!
Chairs, speakers and tentative presentation titles are shown below.
about asahi Kasei Group
asahi Kasei Group is one of Japan's leading industrial companies and a global leader in a diverse range of markets. Its principal operations include chemicals, fibers, electronics, housing, construction materials, pharmaceuticals, medical devices and bioproccess consumables.
The group is structured with asahi Kasei Corporation as a holding company and with core operating companies as wholly owned subsidiaries that perform business in each of the separate industry fields.
What is the site requirements of this website?
This site has been validated to work with the following platforms.
PC Operating System:
- Windows 7 and newer versions
I forgot my password. How do I log in?
You can reset your password here. You will need to fill in your username/e-mail
address you used to register at ak-bio.com in the form provided. a URL to reset your
password will be sent to the specified e-mail.
I would like to send feedbacks on this website.
We welcome your feedbacks! Please send us your comments or feedbacks here.
How do I register for the upcoming Planova™ Workshop?
Please visit the Workshops & Seminars Page for information about the
Workshop and the registration.
I would like to download presentation materials from the last Planova™ Workshop.
Please visit the Search Presentation on the Planova™ Workshop Page. Here, you can find
presentation materials from the last and previous Planova™ Workshops.
I cannot find or download some of the Planova™ Workshop presentation files.
Not all presentation materials at Planova™ Workshops are available for downloads. Only those with the
authors' permissions are available for download on this website.
Relocation of asahi Kasei Medical Headquarter Office
We wish to inform you that the asahi Kasei Medical headquarter office, including the Bioprocess Division Tokyo Office, has relocated to the following new address:
1-1-2 Yurakucho, Chiyoda-ku
Tokyo 100-0006 Japan
The 3rd Planova™ Seminar in Moscow will be held on November 19, 2018
asahi Kasei Bioprocess Europe рады сообщить Вам о проведении 3-его семинара Planova™, который состоится в Москве в соответствии с указанной ниже информацией:
В этом году семинар Planova™ будет организован в преддверии выставки Pharmtech & Ingredients (20-23 ноября 2018).
о использованию фильтров Planova.
abstract Only
Yunoki, M., et al
Japan Blood Products Organization
Nowak, T., et al
Transfusion 57(5) 1184-1191
Open
Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid
Radomski, K., et al
Octapharma Biopharmaceuticals GmbH
Open
Ellgaard, T., et al
Novo Nordisk a/S
Protein Expression and Purification 129 (2017) 94-100
The content of this web site planova.ak-bio.com including information related to our products and services, is provided under the terms and conditions shown here. By using this web site you are deemed to indicate agreement to these terms and conditions: If you do not accept these terms and conditions, do not use this web site.
all content of this web site is protected by applicable copyright laws, regulations, and international treaty. No content from this web site may be copied, modified, or distributed without permission.
Trademarks
Release of the Renewed ak-bio.com Website!
asahi Kasei Bioprocess is pleased to release our website with a new look and improved usability. Specifically, we are hoping that users will able to find information on asahi Kasei Bioprocess and its products and services more easily.
Here are some snapshots of the new features available in our renewed website:
Users are able to find and explore asahi Kasei Bioprocess' products and services relevant to your field of application. You may select from your Protein Type or Development Stage.
Updated list of chairs and speakers for The 21st Planova™ Workshop
We are pleased to announce the following confirmed speakers for the 21st Planova™ Workshop in San Francisco.
■ Confirmed Chairs
ashley Hesslein, Ph.D.
Clarification & Purification Technical Support Services
Learn about our technical support services for our Clarification and Purification solutions. Explore how you can rely to our experts to find solutions to your needs. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency
Our bioprocess technical support team is always responsive in providing solutions to optimize customers' bioprocessing. In order to meet customers' needs, from lab-scale to manufacturing scale, we are driven to apply our technical expertise in maximizing the potential of our unique technology in the fields of impurity removal and purification with chromatography media.
Lab scale
I am using or planning to use your products. Can I request for an audit of your facilities?
Please contact us for audit requests. For Planova™ related products, you can also obtain audit reports via Rx-360, an international pharmaceutical supply chain consortium. For details, please refer to our audit Page.
Can I request a training on how to perform virus filtration?
Yes, we provide complimentary training services tailored to your needs. Please refer to the Training
Services Page for details, and please feel free to contact us with your training request.
How can I get a quotation of your products?
Please contact us citing the name(s) and size(s) or Catalog Number(s) of the product(s) of
interest, and we will get back to you with the necessary information.
The 1st Planova™ Seminar in Moscow
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 1st Planova™ Seminar in Moscow was held as follows:
September 9th and 10th, 2015
The 1st Planova™ Workshop India
In India, the biopharmaceutical industry is growing strongly. The development of biotherapeutics is accelerating at many pharmaceutical companies and preparations for the indigenous production of plasma derivatives are ongoing. In these circumstances, the demand for virus safety in manufacturing processes is increasing rapidly as well.
One of asahi Kasei's core competencies is hollow fiber membrane technology, and it is continually developing new types of filter membranes that carry on its tradition of offering products that deliver high performance and consistency.
In the first Planova™ Workshop held in India, asahi Kasei Medical introduced customer experiences with Planova™ - its industry leading range of hollow fiber virus removal filters, developed through wide-ranging knowledge and technological expertise in material science, mechanical engineering and biopharmaceutical manufacturing within the asahi Kasei Group.
The 3rd announcement of The 19th Planova™ Workshop on September 22 and 23, 2016
We are pleased to present the latest applications and strategies using Planova™ filters at the 19th Planova™ Workshop. Join us and the distinguished speakers and chairs listed in the 3rd announcement in Philadelphia.
The 19th Planova™ Workshop
September 22 and 23, 2016
Site Tour at CTC (Cologne Technical Center) of asahi Kasei Bioprocess Europe on June 20, 2016
We are pleased to announce our Site Tour at CTC (Cologne Technical Center) of asahi Kasei Bioprocess Europe on June 20, 2016 from 13:30-16:30 supported by Informa. It will take place one day before the Viral Safety & Raw Material Conference will start on 21 - 22 June 2016 at Hotel Pullman Cologne, Cologne, Germany.
We are global market leader in virus removal filtration, with Planova™nanofilters having a more than 25 years history of trusted use in biotherapeutics manufacturing.
at our Cologne Technical CTC we want to introduce you our extended services in filterability studies and standardized or "tailor made" training's seminars around our filters and technologies.
10th annual The Bioprocessing Summit
Boston, Ma, USa
http://www.bioprocessingsummit.com/
2018 PDa Europe 11th Workshop on Monoclonal antibodies
Parenteral Drug association
2018 PDa Europe 11th Workshop on Monoclonal antibodies
https://www.pda.org/global-event-calendar/event-detail/11th-workshop-on-monoclonal-antibodies
Life Sciences Baltics 2018
Vilnius, Lithuania
https://lsb2018.com/
Nordic Life Science Days 2018
https://www.nlsdays.com/
Stockholm, Sweden
Parenteral Drug association
2018 PDa Europe Virus Forum
https://www.pda.org/global-event-calendar/speaker-bios/europe/2018-virus-forum
Parenteral Drug association
3rd PDa Europe annual Meeting
https://www.pda.org/conference/3rd-pda-europe-annual-meeting/home/
BioProcess International European Summit
BioProcess International European Summit and Virus Safety Summit
amsterdam, The Netherlands
https://lifesciences.knect365.com/bpieurope/
BioProcess International West
San Francisco, Ca, USa
https://lifesciences.knect365.com/bpi-west/
BioProcess International Conference & Exhibition
https://lifesciences.knect365.com/bioprocessinternational/
Boston, Ma, USa
Final announcement for The 19th Planova™ Workshop on September 22 and 23, 2016
This is the last call for registration to the 19th Planova™ Workshop. Registration closes on September 13.
Join us and the distinguished speakers and chairs listed in the final announcement. We are pleased to present the latest applications and strategies using Planova™ filters.
The 19th Planova™ Workshop
The second announcement of The 19th Planova™ Workshop on September 22 and 23, 2016
We are pleased to present the latest applications and strategies using Planova™ filters at the 19th Planova™ Workshop. Join us and the distinguished speakers and chairs listed in the Second announcement in Philadelphia.
The 19th Planova™ Workshop
September 22 and 23, 2016
Launch of 5L QyuSpeed™ D membrane adsorbers for efficient large scale protein purification
asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch of 5 L QyuSpeedTM D membrane adsorbers. Designed specifically for impurity removal in bioprocessing, QyuSpeedTM D enables biopharmaceutical manufacturers to improve the efficiency and effectiveness of their protein purification steps. The addition of the adsorbers with effective membrane volume of 5 L to the existing product line of 0.6 mL, 150 mL, and 550 mL QyuSpeedTM D provides further flexibility in process implementation of commercial scale biopharmaceutical manufacturing.
about QyuSpeedTM D membrane adsorber
Using the unique grafted chains with high ligand density within the pore structure of its hollow fibers, QyuSpeedTM D achieves three-dimensional multi-point adsorption which enables it to efficiently bind negatively charged biomolecules, such as impurities (host cell proteins, DNa, endotoxin, etc.), viruses, and specific proteins with low isoelectric points (albumin, Iga, IgM, fibrinogen, F-II, F-VIII, F-IX, F-X, PKa, etc.).
IBD™ wins prestigious "Technology of the Decade" award
During the 2012 BioProcessTM International Conference & Exhibition, the IBDTM Inline Buffer Dilution System was named the "Technology of the Decade" in the field of downstream processing.
The award was part of a larger contest in which BioProcess International celebrated their 10th year of publication by honoring technological advances that have transformed the field of bioprocessing during the last ten years.
Debottlenecking downstream processing facilities
Launch of the IBD™ 1K system for debottlenecking downstream processes
Inspired by the need to debottleneck downstream processing facilities and improve processing of high titers in today's purification suites, the new IBDTM 1K system combines innovative engineering and award-winning buffer blending technology to accelerate pilot, clinical and commercial-scale manufacturing.
sents the next step in the evolution of the original IBDTM Inline Buffer Dilution System designed to
about the IBDTM 1K System
Screening, Scale-Up and Validation of Virus Filtration for aggregatable mab Product
Dong-Woo Lee, Manager, Purification Process Team / R&D Center, Celltrion, Inc.
Goa
2nd Planova™ Workshop in India
Screening, Scale-Up and Validation of Virus Filtration for aggregatable mab Product
Dong-Woo Lee, Manager, Purification Process Team / R&D Center, Celltrion, Inc.
Philadelphia
19th Planova™ workshop
Implementation of automatic Cleaning and Integrity Testing of Planova™ Filters
J.F. van de Laar, Plasma Products, Dept. of Process Support and Development, Sanquin
15th Planova™ Workshop
Boston
Process Development for High Concentration Mab with Planova™ BioEX Filter
Roy KaHN, Researcher, DSP, Process Development, InSight Biopharmaceuticals Ltd
athens
18th Planova™ Wokshop
Process Development for High Concentration Mab with Planova™ BioEX Filter
Roy Kahn, Researcher, DSP Process Development, InSight Biopharmaceuticals Ltd.
Goa
2nd Planova™ Workshop in India
The Planova™ Workshop Hainan Is., China was held on January 15, 2015 at the Sanya Marriott Resort & Spa on Hainan Island, China. The number of participants set a new record high for workshops held in the China with distinguished guests in attendance from more than 45 companies and more than a dozen countries. The latest research and applications of asahi Kasei Bioprocess products were shared through presentations by 12 guest speakers and asahi Kasei Bioprocess staff. Oral presentations were divided into the following sessions: Introduction of Virus Safety, Introduction of Virus Filtration, Plasma-Derived Products and Recombinant Products. The presentations of The Planova™ Workshop Hainan Is., China are available online.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
Chairpersons
The 2nd Planova™ Workshop India
We are pleased to announce that the 2nd Planova™ Workshop India will take place in Goa, India on the following dates:
The 2nd Planova™ Workshop India
February 9, 2017
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 15th Planova™ Workshop
Virus filtration and industrial applications of our hallmark Planova™ virus removal filters were the themes of this year’s workshop, with additional emphasis dedicated to the broader field of downstream bioprocessing.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 16th Planova™ Workshop
The 16th Planova™ Workshop was held in Rome on November 7 – 8, 2013. In this workshop, where the number of attendees was the largest in the Planova™ Workshop history, distinguished guests from more than 80 companies of 25 countries shared and exchanged their knowledge and views on recent topics in the biopharmaceutical industry.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 17th Planova™ Workshop
The 17th Planova™ Workshop was held in Washington, D.C. on June 12 to 13, 2014. The number of participants set a new record high for workshops held in the US with distinguished guests in attendance from more than 50 companies and more than a dozen countries.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 18th Planova™ Workshop
The 18th PLaNOVa™ WORKSHOP was held on the 22nd and 23rd of October, 2015 in athens, Greece. The latest research and applications of asahi Kasei Bioprocess products were shared through presentations by 17 speakers. Oral presentations were divided into the following sessions: Regulatory Update and Process Optimization, Process Development, and Manufacturing Technologies and New Trends in Biologics Production. The presentations of The 18th PLaNOVa™ WORKSHOP are available online.
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 19th Planova™ Workshop
The 19th Planova™ Workshop
I need the information on the dimension of Planova™ filters.
Dimensions of each effective surface area size for Planova™ 15N, 20N, 35N, 75N and Planova™
BioEX filters can be found in the respective Product Specification Sheet which can be found in
Technical Documents Page, by putting a check mark on "Product Specification Sheet".
What is the lead time when ordering your products?
If there is availability in local stock point, the minimum lead time is 5 (five) business days. Note that the
lead time may get up to 6 (six) weeks if there is no stock available. Kindly contact us to get the latest
and the most accurate information on lead time and ordering.
I would like to request a trial with your products.
Please feel free to contact us and our representative will be happy to assist you further.
What is the minimum quantity of your products available for purchase?
Our consumable products are available for purchase from one piece. Please feel free to contact us for
more information related to making purchase orders.
Can I use Planova™ filters for uses other than what it is designed for?
Planova™ filters are virus removal filters that are specifically designed for use in the development or manufacture of therapeutic medicinal products, in accordance with the associated usage instructions (i.e., Instructions for Use, Filtration Procedure and Standard Operation Procedure of Integrity Test). Uses other than the above purposes are outside of our scope of use, and we may not provide support services for such uses. also, purchase of Planova™ for such uses shall be at purchaser's sole risk and liability.
Please feel free to contact us and our representatives will be happy to assist you further.
Where can I find Certificates of analysis (COa) samples for your products?
Samples of our Certificates of analysis can be found in Technical Documents Page by putting a check mark on "Safety Data Sheet" under Resource Type. Pleasenote that you need to log in with your ak-bio.com username and password to access the Technical Documents Page.
If you need a sample of COa with a specific product identification code, please contact us.
Where can I find Material Safety Data Sheets (SDS) for your products?
Safety Data Sheets can be found in Technical Documents Page by putting a check mark on "Safety Data Sheet" under Resource Type. Pleasenote that you need to log in with your ak-bio.com username and password to access the Technical Documents Page.
are your products registered or documented with any regulatory authorities?
Drug Master Files for Planova™ 15N, 20N, 35N and 75N filters and Planova™ BioEX filters are on file with the US FDa. Please contact us for further information on our regulatory support services.
Where are your manufacturing facilities located?
Locations of our manufacturing facilities can be found on Our Global Network Page.
are there internship opportunities at asahi Kasei Bioprocess?
Some of our subsidiaries may have internship opportunities open. Please contact us for more details.
Completion of new spinning plant for Planova™ BioEX filters
asahi Kasei Medical has completed the construction of a new plant for the spinning of hollow-fiber membranes for Planova™ BioEX filters at the site of its Planova™ Oita Plant in Oita, Japan.
Planova™ BioEX virus removal filters, which incorporate hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membranes, are used in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives. The hollow-fiber membranes produced at the new spinning plant will be used in the assembly of Planova™ BioEX filters at plants in Oita and Nobeoka. With the new plant, the company's total supply capacity for Planova™ BioEX filters will increase to 10,000 m2/year.
asahi Kasei Medical will continue to contribute to greater safety of biotherapeutic products by developing high-quality and high-performance products in accordance with market needs, while proactively investing in manufacturing facilities.
Ensuring Viral Safety in Recombinant Biotherapeutics
Sudip Kumar Majumder, Principal Scientist & Head, Downstream Process Development, Intas Biopharmaceuticals Limited
Goa
1st Planova™ Workshop in India
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 14th Planova™ Workshop
The 14th Planova™ Workshop
Planova™ 35N Nanofiltration of a Plasma-Derived Immune Globulin Product
Barry D. Gooch, Section Head of Pathogen Safety Development & Validation, R&D Bioscience Industrial Group, North Carolina R&D, Grifols, Inc.
Philadelphia
19th Planova™ Workshop
Planova™ 35N Nanofiltration of a Plasma-Derived Immune Globulin Product
BarryGooch, Senior Research Scientist II, R&D, Pathogen Safety,Grifols
Washington, D.C.
17th Planova™ Workshop
Clarification of Cell Culture Supernatant Using BioOptimal™ MF-SL Modules in Early-Stage R&D
Yuichiro Shimizu,Researcher,ChugaiPharmabody Research
Washington, D.C.
17th Planova™ Workshop
Process Development and Scale-Up of MaBp1 Using Planova™ 20N and QyuSpeedTM D
Josh Combs,Vice President, Manufacturing,XBiotech
Washington, D.C.
17th Planova™ Workshop
Nicola Humpherson,Principal Scientist, Downstream Process Sciences,UCB
Washington, D.C.
17th Planova™ Workshop
Process Designing for Virus Removal Filtration
Tomoko Hongo-Hirasaki,Manager, Bioprocess Technology Development Department,asahi Kasei Medical
Washington, D.C.
17th Planova™ Workshop
Participation at BioProduction Congress 2017
We will exhibit at BioProduction Congress 2017 in Dublin, Ireland on 17-18 October 2017. Please see below for further information.
Date
Location
New Planova™ Oita Plant for Secure Global Supply Chain
Shuji Fujita, Manager,asahi Kasei Medical Co., Ltd.
16th Planova™ Workshop
Rome
Bispecific antibody Purification and Virus Filtration Challenges
Germano Coppola,associate Director, Process Sciences,abbvie Bioresearch Centre Inc.
16th Planova™ Workshop
Rome
Regulatory Update and the Recent Situation in Pathogen Safety
Johannes BLÜMEL, Head of Virus Safety Section, Virology, Paul-Ehrlich-Institut
athens
18th Planova™ Wokshop
asahi Product Development Concept
Terry Sato/Hironobu Shirataki, General Manager/Global Product Manager, asahi Kasei Medical Co., Ltd.
Goa
1st Planova™ Workshop in India
asahi Kasei Corporation announced today the formation of a wholly-owned subsidiary, N.V. asahi Kasei Planova™ Europe S.a., in Belgium and the establishment of a corresponding regional office in Cologne (Koeln), Germany, to provide expanded technical support and customer service to its European customers of Planova™ virus filtration products.
Contact information for N.V. asahi Kasei Planova™ Europe S.a.
Main office - Brussels, Belgium
New Hollow Fiber Spinning Plant for Planova™ Virus Removal Filters
asahi Kasei Medical will construct a new plant to spin hollow-fiber membranes for Planova™ virus removal filters. With a production capacity of 40,000 m²/year the new plant will raise total production capacity from the present 30,000 m²/year to 70,000 m²/year upon completion in March 2009. The new plant will be located adjacent to the Planova™ assembly plant in Nobeoka, Miyazaki, Japan. Planova™ virus removal filters are used to enhance safety in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives. The outstanding performance of Planova™ filters in combining high rates of virus clearance with high rates of protein recovery has been widely recognized throughout the world, and nearly 90% of Planova™ sales are to customers in Europe and the US. With heightened standards throughout the world for the viral safety of biotherapeutics and advances in the development of monoclonal antibodies and other biopharmaceuticals, demand for Planova™ filters is growing briskly. The new spinning plant, together with a new assembly line completed in September 2007, will enable asahi Kasei Medical to meet this growing demand. asahi KaseiMedical is also advancing new product development to meet emerging needs for quality and performance.
Outline of the new spinning plant
Location: Nobeoka, Miyazaki, Japan
The 2nd announcement of The 2nd Planova™ Seminar in Moscow, Russia
We are pleased to release our 2nd announcement of The 2nd Planova™ Seminar in Moscow with Speaker's information, presentation titles and biography.
Date: 6th and 7th of September 2016
Venue: Hotel Metropol Moscow (2 Teatralniy Proezd 109012 Moscow, Russia)
The 3rd announcement of The 2nd Planova™ Seminar in Moscow, Russia
Dear Valued Customer,
We are pleased to release our 3rd announcement of The 2nd Planova™ Seminar in Moscow which includes abstracts and Program. Details can be found in attached files.
We look forward to meeting you in Moscow!
Construction of a new spinning plant for Planova™ BioEX filters
asahi Kasei Medical will construct a new plant for the spinning of hollow-fiber membranes for Planova™ BioEX filters at the site of its Planova™ Oita Plant in Oita, Japan. This addition will increase capacity for Planova™ BioEX filters to 10,000 m2 per year.
Planova™ virus removal filters are used to enhance safety in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives. The outstanding performance of Planova™ filters―combining high rates of virus clearance with high rates of protein recovery―has been widely recognized throughout the world.
Launched in 2009, Planova™ BioEX filters incorporate durable hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membranes that can cope with the harsh processing conditions typical of state-of-the-art biopharmaceutical manufacturing. With its superior viral clearance performance in high protein concentration solutions, Planova™ BioEX filters are increasingly adopted by major pharmaceutical manufacturers, especially in Europe and the US.
a Review of Virus Filter Performance ‒ Critical Process Parameters and Best Practice
Horst Ruppach, Global Director, Viral Clearance and Virology, Charles River
Prague
20th Planova™ Workshop
Christian Koch, Senior Transfer Engineer, Product Transfer & Process Engineering - Protein Purification, Boehringer lngelheim Pharma GmbH & Co. KG
Goa
2nd Planova™ Workshop in India
Implementing Nano Filtration for Platform Manufacturing of Monoclonal antibodies
Girish M. Masand, Deputy General Manager, Therapeutic Proteins - Process Development, Reliance Life Sciences Pvt Ltd.
Goa
2nd Planova™ Workshop in India
Nanofiltration in Plasma-derived IVIG - Process Design for Full Scale Production
alessandra Lazzarotti, Scientist, Industrial Development & Research, Kedrion Biopharma S.p.a.
16th Planova™ Workshop
Rome
FULL PLaSTICS for a 1000L Disposable Production Line for Generic antibody Manufacturing
14th Planova™ Workshop
Peter Rogge, Director, DSP Production, Rentschler Biotechnologie GmbH
Cologne
Implementation of Quality by Design to Nanofiltration of Plasma Products
Monique Ollivier, Director, Process Development-Downstream & analytics, Cytheris S.a.
14th Planova™ Workshop
Cologne
Use of In-house Platform Data to Support Reduced Viral Clearance Validation
Stefan Hepbildikler, Director, Recovery & Downstream Processing C, Roche Pharma Biotech Development
14th Planova™ Workshop
Cologne
Franz Nothelfer, associate Director, Purification Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Goa
1st Planova™ Workshop in India
Franz Nothelfer, associate Director, Protein Science, Boehringer Ingelheim Pharma GmbH & Co. KG
16th Planova™ Workshop
Rome
Michel POULLE, Head of Process Laboratory, Industrial Support Unit, Department of Industrial Processes, LFB Biomedicaments
athens
18th Planova™ Wokshop
Development of a 20 nm Nanofiltration Step for High Purity Fibrinogen Manufacturing Process
Salvador GRaNCHa, Vice-president Research & Development, R&D, Bioscience Industrial Group, Grifols
athens
18th Planova™ Wokshop
Robustness of 15 or 20 nm filtration in manufacturing processes of plasma derived medicinal products
anky KOENDERMaN, Staff member, R&D unit, Sanquin Plasma Products bv
athens
18th Planova™ Wokshop
Virus Safety in Blood Plasma-Derived Products-Planova™ Virus Filtration
XU Tan, Project Manager, Research and Development Division, Chengdu Rongsheng Pharmaceuticals Co., Ltd.
Hainan Island
1st Planova™ Workshop in China
Biotherapeutics and Virus Safety: Relevant Regulations and Guidelines
Herbert Dichtelmüller, ViruSafe-Consult
Goa
1st Planova™ Workshop in India
Marcel asper / Michael Rodemer, Director, Virus Laboratory, Pathogen Safety / Director, Project Manager, BNL,Biotest
Prague
20th Planova™ Workshop
Development of Planova™ 20N Filtration for a Higher Concentration mab: a Case Study
Suhas Rajeeva, Purification Team Lead and associate Scientific Manager, Biocon Research Limited
Goa
2nd Planova™ Workshop in India
Manufacturing Biopharmaceuticals and Biologicals: Current Trends, Challenges and Technology Drivers
Sandeep B. Kale, Deputy Coordinator of DBT-ICT-Centre for Energy Biosciences associate Professor & Co-ordinator for M. Tech. Program, Institute of Chemical Technology
Goa
2nd Planova™ Workshop in India
Current Technologies for Human Plasma-Derived Products
Thierry Burnouf, Director and Professor, Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University
Goa
2nd Planova™ Workshop in India
Indian Perspective : Plasma Derived Medicinal Products
Ranjeet S. ajmani, Chief Executive Officer, PlasmaGen BioSciences Pvt Ltd.
Goa
2nd Planova™ Workshop in India
a General Mechanistic Model for Viral Filtration
anupam Shukla, associate Professor Department of Chemical Engineering, Indian Institute of Technology Delhi
Goa
2nd Planova™ Workshop in India
Virus Retentive Filtration 2017- Regulatory Expectations and Challenges
Horst Ruppach, Global Director Viral Clearance and Virology Charles River, Biologics Testing Solutions
Goa
2nd Planova™ Workshop in India
Defining the Design Spaces for Robust Viral Clearance in Planova™ 20N and BioEX Processes
Daniel Strauss, Senior Scientist Science and Technology, asahi Kasei Bioprocess america, Inc.
Goa
2nd Planova™ Workshop in India
Thomas R. Kreil, associate Professor of Virology Senior Director Global Pathogen Safety, Shire
Goa
2nd Planova™ Workshop in India
Evaluation of asahi Planova™ BioEX Viral Filter Used in Therapeutic antibody Manufacturing Processes
Shengjiang Shawn Liu, Head and Chief Scientist, Pathogen Safety, Biological Development, Bayer HealthCare Pharmaceuticals
Philadelphia
19th Planova™ Workshop
Evaluation of Virus Filtration Operation, Scale Up and Validation for a Fusion Protein
Dharmesh Kanani, Senior Scientist, Downstream Process Development & Operations, Global CMC Biologics, Teva Biopharmaceuticals
Philadelphia
19th Planova™ Workshop
Robust Virus Filtration Processes: Protein Filterability and Viral Clearance
Tomoko Hongo-Hirasak, Manager, Technology Development, Bioprocess, asahi Kasei Medical
Philadelphia
19th Planova™ Workshop
Effective and Robust Virus Filtration
Nathan J. Roth, Senior Director & Head Global Pathogen Safety, CSL Behring
Philadelphia
19th Planova™ Workshop
asahi Gold Particle Test System (aGPTS) : Confidence in automation
Michael Proctor, Manager, Zemaira Manufacturing, CSL Behring
Philadelphia
19th Planova™ Workshop
Pressure and Flow Variations, Filter Integrity Testing: Robustness Questions answered?
Thomas R. Kreil, associate Professor of Virology, Senior Director, Global Pathogen Safety, Shire
Philadelphia
19th Planova™ Workshop
Regulatory Update on Virus Safety of Biological Products
Johannes Blümel, Head of Virus Safety Section, Virology, Paul-Ehrlich-Institut
Philadelphia
19th Planova™ Workshop
Effects of Pressure and Process Pausing on Viral Removal During Viral Filtration
Sean O'Donnell, Senior Research Scientist, Virology and Purification Development, Eli Lilly and Company
Philadelphia
19th Planova™ Workshop
Fine Tuning Viral Clearance approaches with a Total Viral Load Strategy
Michael Burnham, Director, Purification and Process Development, WuXi appTec, Inc.
Philadelphia
19th Planova™ Workshop
Filtration Study to Remove Mycoplasma acholeplasma laidlawii with Planova™ 20N and BioEX Filters
Masayasu Takahara, Manager, Technical Marketing, Bioprocess, asahi Kasei Medical Co., Ltd.
Philadelphia
19th Planova™ Workshop
Scalability of Planova™ BioEX Filters
Daniel Strauss, Senior Scientist, Science and Technology, asahi Kasei Bioprocess america, Inc.
Philadelphia
19th Planova™ Workshop
Josh Goldstein, Senior Scientist, aPI-LM, Pharmaceutical Development and Manufacturing Sciences, Janssen Research & Development, LLC
Philadelphia
19th Planova™ Workshop
Highly Effective and Robust Virus Filtration Design for Early Phase and Commercial Processes
Nathan J ROTH, Director/Head Global Pathogen Safety, R&D, CSL Behring
athens
18th Planova™ Wokshop
approach for Phage Risk Mitigation Using Virus Filter
Simon HaIDINGER, Head of Upstream Development I, Biopharmaceuticals Process Science austria, Boehringer Ingelheim RCV GmbH & Co KG
athens
18th Planova™ Wokshop
Nanofiltration on Culture Media to Secure Cell and Viral Banks
Landry BERTaUX, Cell and viral culture Scientist, Bioprocess R&D, Sanofi Pasteur
athens
18th Planova™ Wokshop
Planova™ Filter in the Production Process of a Gene Therapy Product
Leila DIaS, Scientist DSP, Process Development, uniQure N.V.
athens
18th Planova™ Wokshop
Eckhard FLECHSIG, Senior Director Pathogen Safety, Global Research, Biotest aG
athens
18th Planova™ Wokshop
Process Development for High Concentration Mab with Planova™ BioEX Filter
Roy Kahn, Ph.D, Researcher, DSP, Process Development, InSight Biopharmaceuticals Ltd.
Philadelphia
19th Planova™ Workshop
audit Reports for Planova™ Manufacturing Facilities available for Purchase from Rx-360
asahi Kasei Medical Co., Ltd. is pleased to inform that audit reports for Planova™ Plant and Planova™ Oita Plant are now available for purchase from Rx-360, an international pharmaceutical supply chain consortium.
Purchasing these audit reports allows biopharmaceutical companies to obtain audit reports for Planova™ manufacturing facilities without having to conduct the audits directly, which could potentially help to save time and costs. Other features and benefits of purchasing the audit reports are as follows:
･ Companies could save time and cost of traveling to Miyazaki and Oita, Japan.
The 19th Planova™ Workshop will take place on September 22 and 23, 2016
We are pleased to announce that the 19th Planova™ Workshop will take place in Philadelphia, Pa on the following dates:
The 19th Planova™ Workshop
September 22 and 23, 2016
Report of the 1st Planova™ Seminar in Moscow, Russia
We are pleased to announce the successful conclusion of the 1st Planova™ Seminar in Moscow, Russia held in September 2015. More than 40 participants took part in this event held at Metropol Hotel Moscow, which featured the following distinguished speakers.
Dr. Thierry BURNOUF, Ph.D., Director, Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University, Taiwan
Presentation 1: Plasma Fractionation and Plasma Product Market: Historical Perspectives and Trends
We would like to hear from you about our website!
asahi Kasei Bioprocess always strives to improve what we provide to our customers, and we would like to do so by collaborating with you. Please take a moment to tell us about your experience with the asahi Kasei Bioprocess website (www.ak-bio.com) by responding to the questions in the survey below:
https://questant.jp/q/asahikaseibioprocess
The survey will take about 10-15 minutes to complete. You will be asked to enter a password to proceed with the survey, which is: akbsurvey2017.
The 21st Planova™ Workshop will be held in San Francisco on October 11-12, 2018
The 20th Planova™ Workshop held in Prague came to a successful conclusion. We were honored to host about 200 participants in Prague, and we were pleased to have many valuable exchanges.
The workshop presentations are now available to registered users at our website.
The 20th Planova™ Workshop page
additional Technical Documents Now available at the Library
er to improve this website's user convenience, we are pleased to inform you that more technical docu
In case you do not have an account at ak-bio.com yet, please register here and enjoy the benefits of being able to download various technical documents as well as Planova™ Workshop presentation materials at your fingertips.
We thank you for your continuous support and we will work to continuously improve user experience of ak-bio.com.
Registration Now Open for The 21st Planova™ Workshop in San Francisco
Registration is now open for The 21st Planova™ Workshop in San Francisco. Please visit the Workshop page for links to the Registration Form and to reserve hotel accommodations at reduced rates. The 21st Planova™ Workshop page
The Planova™ Workshop is an opportunity for Planova™ users to share experiences and to learn the best practices of virus filtration. Event chairs and speakers at this annual event are key industry leaders in biotherapeutics, and their presentations cover topics such as tips for process optimization, validations, regulatory requirements and scaling up to commercial manufacturing. Event attendees are professionals in the fields of regulation, process development, pathogen safety, quality and manufacturing.
This year we are coordinating with Charles River Laboratories to bring you Viral Safety Week. Charles River, an international corporation providing services and products to support the entire drug discovery and development continuum, will hold its 3rd annual Viral Clearance and Viral Safety Summit earlier in the week.
Franz NOTHELFER, associate Director Protein Science, Biopharmaceuticals, Process Development, Boehringer Ingelheim Pharma GmbH & Co. KG
athens
18th Planova™ Wokshop
Use of MF-SL and Planova™ 20N in the Factor V manufacturing process in Kedrion
Silvia NaNNIZZI, Scientist, Industrial Development and Research, Kedrion Spa
athens
18th Planova™ Wokshop
Defining the Design Spaces for Robust Viral Clearance in Planova™ 20N and BioEX Filter Processes
Daniel STRaUSS, Senior Scientist, Science and Technology, asahi Kasei Bioprocess america
athens
18th Planova™ Wokshop
Virus filtration studies and manufacturing processes: does equivalence need a fresh look?
andreas WIESER, Senior Laboratory associate, Global Pathogen Safety, Baxalta
athens
18th Planova™ Wokshop
Tomoko HONGO-HIRaSaKI, Manager, Technology Development, Bioprocess Division, asahi Kasei Medical
athens
18th Planova™ Wokshop
asahi Kasei Medical Product Development Concept
MIYaBaYaSHI Tomoyuki, General Manager, Technical Marketing Department, asahi Kasei Medical Co., Ltd.
Hainan Island
1st Planova™ Workshop in China
State of the art Manufacturing of Biotechnological Products
albrecht GROENER, Head Pathogen Safety, CSL Behring
Hainan Island
1st Planova™ Workshop in China
Current Situation of Viral Clearance for Biological Products in China
FU Rui, Vice Senior Investigator, Division of Laboratory animal Monitoring, National Institutes for Food and Drug Control
Hainan Island
1st Planova™ Workshop in China
Nanofiltration in IVIG Chromatography Manufacturing Process
Ma Shan, Head of Research and Development Division, Joint Venture, Shandong Taibang Biological Products Co., Ltd.
Hainan Island
1st Planova™ Workshop in China
State of the art of the IVIG Manufacturing
Sami CHTOUROU, Executive Vice President, Innovation & Scientific affairs, LFB Biotechnologies
Hainan Island
1st Planova™ Workshop in China
Blood Products Safety and Regulation in China
HOU Jifeng, Head of Blood Products Division, National Institutes for Food and Drug Control
Hainan Island
1st Planova™ Workshop in China
Validation of Virus Filtration Steps
Joseph V. HUGHES, Chief Scientist, Virology, Vice President- Technical Development, WuXi appTec Inc.
Hainan Island
1st Planova™ Workshop in China
Planova™ Filters: Virus Removal from Bio-therapeutic Products
LIU Zhanjie, Deputy Manager of Shanghai Representative Office, Bioprocess Division, asahi Kasei China Co., Ltd., China
Hainan Island
1st Planova™ Workshop in China
Thierry BURNOUF, Director, Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University, Taiwan
Hainan Island
1st Planova™ Workshop in China
Pathogen Safety of Biological Medicinal Products
Thomas R.KREIL, associate Professor of Virology, Senior Director Global Pathogen Safety, BaxterBioScience
Hainan Island
1st Planova™ Workshop in China
Perspective of Plasma-Derived Products in China
LIU Wenfang, Professor, Institute of Blood Transfusion, Chinese academy of Medical Sciences/ Peking Union Medical College
Hainan Island
1st Planova™ Workshop in China
Virus Filtration and Biotechnology Processes
Thomas Kreil, associate Professor of Virology at the Medical University of Vienna and Senior Director, Global Pathogen Safety, Baxter BioScience
Washington, D.C.
17th Planova™ Workshop
Use of Porcine Circovirus as a Challenge for Filtration and Other Virus Risk Mitigation Steps
Kathryn Martin Remington, Principal Scientist, Clearance Services, BioReliance
Washington, D.C.
17th Planova™ Workshop
asahi Gold Particle Test System Development and Implementation Case Study
Kimo Sanderson, Vice President, Client Services, asahi Kasei Bioprocess
Washington, D.C.
17th Planova™ Workshop
Natascha Hodosi, GLP Study Director, ViruSure
Washington, D.C.
17th Planova™ Workshop
Implementation of the Planova™ Virus Reduction Filter into an Established Manufacturing Process
andrew Griffiths, Scientist, Process Support, Biosciences, Emergent BioSolutions
Washington, D.C.
17th Planova™ Workshop
Regulatory Update on Virus Safety with a Focus on Nanofiltration
Johannes Blümel, Head of Virus Safety Section, Virology, Paul-Ehrlich-Institut
Washington, D.C.
17th Planova™ Workshop
Daniel Strauss, Senior Scientist, Science and Technology, asahiKasei Bioprocess
Washington, D.C.
17th Planova™ Workshop
Interruption of Filtration and Residual Virus in the Filtrate
Herbert Dichtelmüller, President, ViruSafe-Consult
Washington, D.C.
17th Planova™ Workshop
Virus Filter Breakthrough Modes and Risk Mitigation Strategies
Kurt Brorson, Scientist, CDER, FDa
Washington, D.C.
17th Planova™ Workshop
Virus Removal is affected by Flux, Brownian Motion of Virus and Virus-Membrane Interaction
Oscar Jun adan-Kubo, Lead Researcher, Protein Pharmacology Research Section, Japan Blood Products Organization
Washington, D.C.
17th Planova™ Workshop
Determination of Viral Clearance Design Spaces on Planova™ 20N and BioEX Filters
Josh Goldstein, Scientist, Pharmaceutical Development and Manufacturing Sciences, Janssen Research & Development
Washington, D.C.
17th Planova™ Workshop
The application of Planova™ BioEX in the Plasma-Derived IVIG Manufacturing Process
Yang HuHu, Engineer, Shandong Taibang Biological Products, Co., Ltd.
16th Planova™ Workshop
Rome
Structure of Filter Membrane and Brownian Motion of Virus affects Virus Removal
Oscar Jun adan-Kubo, Lead Researcher, Japan Blood Products Organization
16th Planova™ Workshop
Rome
Francisco J. Belda, Head Virology Section, Instituto Grifols S.a.
16th Planova™ Workshop
Rome
Introduction of automated Planova™ Filtration Systems at Janssen Biologics B.V.
Guido Ragetlie, Principal Engineer, Janssen Biologics B.V.
16th Planova™ Workshop
Rome
Daria Popova, Research Engineer, Department of Biochemical Engineering, University College London
16th Planova™ Workshop
Rome
luemel, Dr. Kreil, Mr. Nothelfer, Dr. Hongo, Mr. Sato, Dr. Ruppach, Dr.Bailey
16th Planova™ Workshop
Rome
Characteristics and Optimum Selection of Planova™ Virus Removal Filters
Tomoko Hongo-Hirasaki, Manager, asahi Kasei Medical Co., Ltd.
16th Planova™ Workshop
Rome
Large Volume Filtration with Novel Virus Preparation Method
Kazuya Kobayashi, R&D Staff, asahi Kasei Medical Co., Ltd.
16th Planova™ Workshop
Rome
Process Development and Scale-up of Planova™ 20N Filters
Solomon alva, Scientific Manager, Research & Development, Biocon Limited
Goa
1st Planova™ Workshop in India
Development of Viral Filtration Process for Monoclonal antibody
Lalit Saxena, Manager, Production, Mabpharm Private Limited
Goa
1st Planova™ Workshop in India
Improvement of Mab Production Cost
Sami Chtourou, Senior Vice President, Innovation and Scientific affairs, LFB Biotechnologies
Goa
1st Planova™ Workshop in India
Process Designing for Virus Removal Filter
Tomoko Hongo-Hirasaki, Manager, Technology Development Department, asahi Kasei Medical Co., Ltd.
14th Planova™ Workshop
Cologne
Comparison of Downscale and Process Virus Retentive Filter
Marcel asper, Study Director, Charles River Biopharmaceutical Services GmbH
14th Planova™ Workshop
Cologne
Selection of a Virus Filter for a Plasma Product
Shirley Stagg, Senior Project Scientist, Biosafety and Product Development, Bio Products Laboratory Ltd.
14th Planova™ Workshop
Cologne
Experience with Reduction of Small Non-enveloped Viruses
Johannes Blümel, Head of virus safety section, Paul Ehrlich Institute
14th Planova™ Workshop
Cologne
Santiago Caballero, Santiago Caballero, Ph.D., Instituto Grifols, S.a.
14th Planova™ Workshop
Cologne
Parameters Impacting Pathogen Removal Capacity of Virus Filters - General Considerations
albrecht Gröner, Head Pathogen Safety, CSL Behring
15th Planova™ Workshop
Boston
Process evaluation and search for devices for prion removal using mouse adapted vCJD
Oscar Jun adan-Kubo, Research Scientist, Infectious Pathogen Research Group, R&D, Benesis Corporation
15th Planova™ Workshop
Boston
Development of a Viral Filtration Step
Erich Blatter, Senior Scientist, Purification Sciences Human Genome Sciences, Inc.
15th Planova™ Workshop
Boston
Tom Belval, Principal Engineer, Global Process Engineering, amgen
15th Planova™ Workshop
Boston
Plasma Fractionation - Current Technologies and New Trends -
Sami Chtourou, Senior Vice President, Innovation and Scientific affairs, LFB Biotechnologies
Goa
1st Planova™ Workshop in India
Brian BUESING, Research associate, Science and Technology, asahi Kasei Bioprocess america, Inc.
athens
18th Planova™ Wokshop
Preparation of Plasma Meeting Requirements for Contract or Domestic Fractionation
Thierry Burnouf, Director, Human Protein Process Sciences
Goa
1st Planova™ Workshop in India
Planova™ Filters - Virus Removal from Biotherapeutic Products -
Ravinder Dabas, Manager, asahi Kasei India Private Limited
Goa
1st Planova™ Workshop in India
Plasma Derivatives and Virus Safety: Relevant Regulations and Guidelines - an Industry Perspective -
Herbert Dichtelmüller, ViruSafe-Consult
Goa
1st Planova™ Workshop in India
Implementation of Nanofiltration in the Production Process of Gonadotropins
José Groisman, Director, R&D, Massone S.a.
15th Planova™ Workshop
Boston
Development of Nanofiltered High Purity Fibrinogen
Salvador Grancha, Research and Development area, Instituto Grifols S.a.
15th Planova™ Workshop
Boston
Evaluation of lgG Throughput in Selected Commercial Virus Filters
Joseph Bertolini, R&D Manager, CSL Biotherapies
15th Planova™ Workshop
Boston
Virus Filtration and Biotechnology Processes
Thomas Kreil,associate Professor of Virology, Senior Director Global Pathogen Safety, Baxter BioScience
16th Planova™ Workshop
Rome
Filtration Robustness of Planova™ BioEX Virus-Removal Filter
Tomoko Hongo-Hirasaki, Manager, Technology Development Department, Bioprocess Division, asahi Kasei Medical Co., Ltd.
15th Planova™ Workshop
Boston
Investigations of PCV Removal by Planova™ Filters Smaller than 15 nm
andy Bailey, CEO and Operations Director, ViruSure GmbH
16th Planova™ Workshop
Rome
Regina Voges-Haas, Head of Laboratory Development Plasma Proteins, Biotest aG
16th Planova™ Workshop
Rome
Integrity Testing of Planova™ BioEX Virus Removal FiltersBioEX Virus Removal Filters
Shinya Sekine, Manager, Technology Development Department Bioprocess Division, asahi Kasei Medical Co., Ltd.
15th Planova™ Workshop
Boston
Viral Filtration of Enzyme Therapeutics Using Planova™ 15N and Planova™ 20N filters
Mei Huei Jang, Senior Scientist, Purification Process Development, Shire Pharmaceuticals
15th Planova™ Workshop
Boston
The Purity of Virus Spikes: Influences on the Performance of Virus Removal Filters
Joseph Hughes, Chief Scientist of Virology and Vice President for Service Development, WuXi appTec, Inc.
15th Planova™ Workshop
Boston
PDa Technical Report 41: Virus Filtration - History and the Future
Kurt Brorson, Staff Scientist, CDER, FDa
15th Planova™ Workshop
Boston
New Concept of Integrity Test for Planova™ BioEX
Shinya Sekine, Manager, Technology Development Department, asahi Kasei Medical Co., Ltd.
14th Planova™ Workshop
Cologne
Filtration Study of Planova™ BioEX in the Plasma-derived IvIG Manufacturing Process
Shao Yujuan, R&D Project Leader, Research and Development, Shandong Taibang Biological Product
Goa
1st Planova™ Workshop in India
Plasma Protein Therapy: Current Scene in India and SaaRC Region
Ranjeet S. ajmani, Chief Executive Officer, PlasmaGen BioSciences Pvt. Ltd
Goa
1st Planova™ Workshop in India
J.F. van de Laar, Plasma Products, Dept. of Process Support and Development, Sanquin
14th Planova™ Workshop
Cologne
Michael Dieterle, associate Director Downstream Development, Boehringer Ingelheim GmbH&Co.KG
14th Planova™ Workshop
Cologne
Dayue Chen, Virology Group Bioprocess Research and Development, Eli Lilly and Company
14th Planova™ Workshop
Cologne
The 3rd announcement of The Planova™ Workshop athens, Greece on October, 2015.
We are pleased to announce that the 18th Planova™ Workshop will take place in athens, Greece on the following dates:
18th Planova™ WORKSHOP
October 22 and 23, 2015
Exhibition Information in 2016
We are pleased to announce scheduled participation in exhibitions in 2016. Click here.
Construction of new spinning plant for Planova™ filters
asahi Kasei Medical will construct a new plant for the spinning of cellulose hollow-fiber membranes for Planova™ virus removal filters in Nobeoka, Miyazaki, Japan, increasing annual production capacity by 40,000 m²/year upon completion in May 2019.
Virus removal filters are used to enhance safety in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives. asahi Kasei Medical has earned wide recognition among customers around the world for the performance and reliability of its virus removal filters―both Planova™ cellulose membrane filters, which were launched in 1989 as the world's first filters developed specifically for removing viruses from biotherapeutic products, and Planova™ BioEX hydrophilic PVDF (polyvinylidene fluoride) membrane filters, which provide superior viral clearance in high protein concentration solutions. With heightened standards throughout the world for the viral safety of biotherapeutics and advances in the development of monoclonal antibodies and other biopharmaceuticals, global demand for Planova™ filters is expected to continue on growing. The new spinning plant will enable asahi Kasei Medical to maintain stable product supply and meet rising demand. Together with a spinning plant for Planova™ BioEX filters completed in Oita, Japan, in 2016, the new spinning plant announced today will increase asahi Kasei Medical's total production capacity for hollow-fiber virus removal membranes to 130,000 m²/year.
asahi Kasei Medical will continue to contribute to greater safety of biotherapeutic products by developing high-quality and high-performance products in accordance with market needs, while proactively investing in manufacturing facilities.
Limited Free access: a Case Study on Planova™ BioEX Was Published on Biologicals
Recently, a study titled "Validation and implementation of Planova™ BioEX virus filters in the manufacture of a new liquid intravenous immunoglobulin in China" was published on Biologicals (Ma et al, 2018). The study reports the development and optimization of a manufacturing-scale virus removal step for intravenous immunoglobulin (IVIG) using Planova™ BioEX.
From the results, it was demonstrated that improved viral safety of IVIG can be assured by implementing a virus removal step using Planova™ BioEX to ensure effective parvovirus clearance. Furthermore, excellent protein recovery was achieved and there was no detectable impact on product biochemical properties.
The article can be accessed for free for a limited period of time - anyone clicking on the link below before May 29, 2018 will be taken directly to the final version of the article on ScienceDirect. No sign up, registration or fees are required - you can simply click and read here.
The Planova™ Seminar in Beijing will take place on March 10, 2017
We are pleased to release our announcement of The Planova™ Seminar in Beijing. Details can be found in the attached file. We look forward to meeting you in Beijing!
我们计划在3月10号在北京召开PLaNOVa™ 病毒过滤器技术说明会，详细日程请参见附件。
Planova Beijing Seminar.pdf
The 20th Planova™ Workshop was successfully held in Prague, Czech Republic on November 9 and 10, 2017. The Workshop was attended by more than 200 speakers and participants, where fruitful exchanges of knowledge and case studies on viral safety and virus filtration were made. Presentations by 15 distinguished speakers on Fundamental Knowledge, Process Development, Robust Manufacturing and New Trends were shared. Furthermore, as the year 2017 sees a double anniversary of Planova™ virus removal filters, where Planova™ Workshop was held for the 20th time and it marks the 30th anniversary of the start of the Planova™ business, a Keynote Presentation was presented by the inventor of virus removal filter, Seiichi Manabe.
The biographies of the presenters and the presentation materials shared during the Workshop are now available for download on Workshop page (you will need your user ID and password to download).
asahi Kasei Bioprocess would like to thank all speakers and participants for their contribution to the great success of the 20th Planova™ Workshop, and we hope that the materials provided are useful in promoting the global advancement, safety and manufacturing efficiency of biopharmaceutical industry.
Participation at BioPharma asia Convention 2014 in Singapore
asahi Kasei Bioprocess Singapore Pte. Ltd. will exhibit at BioPharma asia Convention 2014, which will be held in Singapore on March 10 - 13. There will be a presentation on virus removal by Naoto Watanabe, Managing Director on March 12. Please see below for further information.
BioPharma asia Convention 2014
Date
Participation at Biological Production Forum 2014 in Dublin, Ireland
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at Biological Production Forum 2014, which will be held in Dublin, Ireland on May 12 - 14. There will be a workshop presented by Stefan Schrankler, Senior Product and Marketing Manager on May 13. This workshop will focus on virus and phage removal by nanofiltration using Planova™ filters. Please see below for further information.
Biological Production Forum 2014
Date
Guest Speakers and Workshop Chairs ― the 17th Planova™ Workshop
asahi Kasei Bioprocess, Inc. is pleased to welcome the following guest speakers and workshop chairs to the 17th Planova™ Workshop, which will be held in Washington, D.C., USa on June 12 - 13, 2014.
Guest Speakers:
Oscar Jun adan-Kubo, Ph.D., Lead Researcher, Infectious Pathogen Research Section, Japan Blood Products Organization (JBPO)
Participation at Viral Safety for Biologics in Cologne, Germany
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at Viral Safety for Biologics in Cologne, Germany on June 24-25.Please see below for further information.
Viral Safety for Biologics
Date
availability of the presentation materials of the 17th Planova™ Workshop held in June 2014
We are pleased to announce that the presentation materials of the 17th Planova™ Workshop are now available in this website. The workshop took place in Washington, D.C., United States in June 12 - 13, 2014. The materials can be downloaded here (please note that your login ID and password are necessary for download).
The movies of the presentations will be also available and we will announce the availability in due course.
We would like to thank all speakers and participants for their contribution to the great success of the 17th Planova™ Workshop, and we hope that the presentation materials provided above are useful in promoting the global advancement of biopharmaceutical industry.
announcing partial list of confirmed speakers for the 21st Planova™ Workshop
We are pleased to announce the following confirmed speakers for the 21st Planova™ Workshop in San Francisco.
Doug MacDonald
Seattle Genetics
The Planova™ Workshop Hainan Is., China will take place on January 15, 2015
asahi Kasei Medical Co., Ltd. is pleased to announce that the Planova™ Workshop Hainan Is., China will take place on January 15, 2015 at the Sanya Marriott Resort & Spa on Hainan Island, China.
In China, the plasma derivatives and biopharmaceutical industries are growing quickly, and at the same time, safety issues related to these products have become one of the biggest concerns in the industry. Consequently, the need for virus removal filters is becoming greater and greater.
Planova™ filters were the first filters developed specifically for removing viruses from biotherapeutics. Since their launch in 1989, Planova™ filters have built up a record of proven safety and reliability in the biotherapeutic industry internationally, including in China.
The Second announcement of The Planova™ Workshop Hainan Is., China on January 15, 2015
asahi Kasei Medical Co., Ltd. is pleased to inform the second announcement of the Planova™ Workshop Hainan Is., China will take place on January 15, 2015 at the Sanya Marriott Resort & Spa on Hainan Island, China.
In China, the plasma derivatives and biopharmaceutical industries are growing quickly, and at the same time, safety issues related to these products have become one of the biggest concerns in the industry. Consequently, the need for virus removal filters is becoming greater and greater.
Planova™ filters were the first filters developed specifically for removing viruses from biotherapeutics. Since their launch in 1989, Planova™ filters have built up a record of proven safety and reliability in the biotherapeutic industry internationally, including in China.
Video presentations from the 17th Planova™ Workshop are now available
We are pleased to announce that video presentations from the 17th Planova™ Workshop are now available for viewing on this website. The workshop took place June 12 and 13, 2014 in Washington, D.C., United States. The videos are available here(please note that login ID and password are required).
again, we would like to thank all speakers and participants for their contributions to the great success of the 17th Planova™ Workshop. We hope that these presentations help as we all continue to promote advancement in the global biopharmaceutical industry.
availability of the presentation materials of the Planova™ Workshop Hainan Is., held in January 2015
We are pleased to announce that the presentation materials of the Planova™ Workshop Hainan Is., are now available in this website. The workshop took place in Hainan Is, China in January 15, 2015. The materials can be downloaded (please login with your ID and password before download.) here.
The movies of the presentations will be also available and we will announce the availability in due course.
We would like to thank all speakers and participants for their contribution to the great success of the Planova™ Workshop Hainan Is., and we hope that the presentation materials provided above are useful in promoting the global advancement of biopharmaceutical industry.
The second announcement of The Planova™ Workshop athens, Greece on October, 2015.
We are pleased to announce that the 18th Planova™ Workshop will take place in athens, Greece on the following dates:
18th Planova™ WORKSHOP
October 22 and 23, 2015
Video presentations from the Planova™ Workshop Hainan Is. are now available
We are pleased to announce that video presentations from the Planova™ Workshop Hainan Is. are now available for viewing on this website. The workshop took place in Hainan Is, China in January 15, 2015. The videos are available (please login with your ID and password before download.) here.
again, we would like to thank all speakers and participants for their contributions to the great success of the Planova™ Workshop Hainan Is. in China. We hope that these presentations help as we all continue to promote advancement in the global biopharmaceutical industry.
Participation at IMMUNOPHaRMaCOLOGY - VaCCIPHaRMa in Varadero, Cuba
We will exhibit at IMMUNOPHaRMaCOLOGY - VaCCIPHaRMa in Varadero, Cuba on June 14-19, 2015. Please see below for further information.
IMMUNOPHaRMaCOLOGY - VaCCIPHaRMa
Date
Participation at BioProduction 2015
We will exhibit at BioProduction 2015 in Dublin, Ireland on 14-15 October 2015. Please see below for further information.
Date
Location
We are pleased to announce that the presentation materials of the 18th Planova™ WORKSHOP, are now available in this website. The workshop took place in athens, Greece on 22nd and 23rd of October, 2015. The materials can be downloaded (please login with your ID and password before download.) here .
The movies of the presentations will be also available and we will announce the availability in due course.
We would like to thank all speakers and participants for their contribution to the great success of the 18th Planova™ WORKSHOP, and we hope that the presentation materials provided above are useful in promoting the global advancement of biopharmaceutical industry.
The 17th Planova™ Workshop to be held in Washington, D.C.
We are pleased to announce that the 17th Planova™ Workshop will take place in Washington, D.C. on the following dates:
17th PLaNOVa™ WORKSHOP
June 12 and 13, 2014
asahi Kasei Corporation Develops Planova™ Virus Removal Filters with Larger Membrane Surface area
asahi Kasei Corporation today unveiled Planova™ virus removal filters with effective surface areas of 4.0 m² for the Planova™ 15N, 20N, and 35N filter lines. Representing a four-fold increase over the current largest effective membrane size of 1.0 m², the new 4.0 m² filters reduce the number of filters needed for a manufacturing cycle and the overall time required for filter integrity testing.
Employing a filter housing that is two-fold larger in diameter and equivalent in length to the housing of the current 1.0 m² Planova™ filters, the 4.0 m² filters can easily be integrated into existing manufacturing operations. Filter components meet the USP Biological Reactivity Test, in vivo, for Class VI plastics.
Commercial release is scheduled to begin in early December 2002.
Formation of asahi Kasei Pharma Corporation
asahi Kasei Corporation today organized all of its healthcare-related businesses under its newly formed, wholly owned subsidiary asahi Kasei Pharma Corporation. asahi Kasei Pharma includes asahi Kasei businesses in pharmaceuticals, pharmaceutical intermediates, diagnostics, and biopharmaceutical/biological filtration products for virus removal under the Planova™ brand name.
The establishment of asahi Kasei Pharma is an integral part of a transformation program at asahi Kasei Corporation to a holding company configuration to enhance management speed and transparency. Under this transformation program, all asahi Kasei core businesses have been separated into seven separate business units and a new system of executive officer management has been established to facilitate quick response to changing business environments and clear delineation of authority and responsibility.
about asahi Kasei Corporation
Transfer of Planova™ Business to asahi Kasei Medical
The Planova™ virus removal filter business has been transferred from asahi Kasei Pharma Corp. to its subsidiary asahi Kasei Medical Co., Ltd. The combination will enable synergy to be obtained between the membrane and filtration technologies of Planova™ and those of asahi Kasei Medical's therapeutic and blood transfusion devices.
The Planova™ Division, as a discrete operating unit, has been transferred in its entirety; all production and distribution systems, sales and support personnel, and other contacts and relationships remain unchanged.
Planova™ Filters
asahi Kasei Bioprocess, Inc. unveiled the new standard Virus Filtration Controller equipped to remove viruses from biopharmaceuticals and plasma derivatives. The Virus Filtration Controller is a robust system that performs automated, consistent virus-removal using Planova™ filters for pilot, clinical, and commercial-scale manufacturing. The modest footprint of 864 mm x 686 mm (34" x 27") accommodates the majority of downstream processing facilities. Similarly, new features such as built-in vertical Visual Leak Testing coupled with customary virus filtration operations such as equilibration, filtration, and washing elevate Planova™ functionality to unprecedented levels.
Changing the landscape of virus filtration
Large filtration systems are no longer conducive to biologics manufacturing plants faced with limited floor space. Simultaneously, virus removal during downstream processing has become increasingly more complex given the unique requirements of individual candidate molecules. The Virus Filtration Controller addresses these needs by offering:
Completion of a New assembly Plant for Planova™ Virus Removal Filters
asahi Kasei Medical Co., Ltd. has completed construction of a new plant for assembly of Planova™ virus removal filters in Oita, Japan. With capacity of 40,000 m²/year, the new plant doubles total production capacity for Planova™ filters to 80,000 m²/year.
Planova™ virus removal filters are used to enhance safety in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives. The outstanding performance of Planova™ filters--combining high rates of virus clearance with high rates of protein recovery--has been widely recognized throughout the world, and over 90% of Planova™ sales are to customers in Europe and the US. Demand for Planova™ products is poised for steady growth, with production of biopharmaceuticals forecasted to grow at over 10% per year until 2015.
The newly completed plant complements asahi Kasei Medical's plants in Nobeoka, Miyazaki, Japan, for the spinning of hollow-fiber membrane and the assembly of Planova™ filters. Being located in Oita, one of the main production sites for medical devices and related products of the asahi Kasei Group, the new plant will serve to reduce location risk in Planova™ production. This expansion of capacity underscores asahi Kasei Medical's commitment as the market leader to maintain stable supply and high product quality in line with growing demand.
Launch of BioOptimal™ MF-SL Microfilters for Bioprocessing
asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on august 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™ MF-SL filters enable biopharmaceutical manufacturers to improve the efficiency and effectiveness of their protein harvest step.
Developed using asahi Kasei's unique technology base in hollow-fiber filtration and polymer science, BioOptimal™ MF-SL filters offer superior filtration performance that results in faster processing times and higher-quality protein streams, even when filtering high-density cell culture solutions. The unique hollow-fiber membrane structure used in BioOptimal™ MF-SL filters enables gentle processing of cells and proteins in tangential flow mode, which reduces the burden on subsequent processing steps, and additionally makes BioOptimal™ MF-SL filters suitable for use in perfusion-based fermentation processes.
The key features of BioOptimal™ MF-SL are as follows:
Participation in exhibition/conference in Istanbul, Turkey
asahi Kasei Bioprocess Europe N.V./S.a. is pleased to announce its participation in the following exhibition/conference.
Event Name
Biosimilars in Turkey, MENa & Russia
Participation in exhibition/conference in Nagoya, Japan
asahi Kasei Medical Co., Ltd. is pleased to announce its participation in the following exhibition/conference.
Event Name
The 25th annual and International Meeting of the Japanese association for animal Cell Technology (JaaCT2012)
Participation in exhibition/conference in Mumbai, India
asahi Kasei Medical Co., Ltd. is pleased to announce its participation in the following exhibition/conference.
Event Name
BioPharma India Convention 2012
availability of presentation materials of the 15th Planova™ Bioprocess Workshop held in June 2012
We are pleased to announce the availability of presentation materials of the 15th Planova™ Bioprocess Workshop, which took place in Cambridge, Massachusetts on June 14-15, 2012. The materials can be downloaded from here (please note that login ID and password are required for download).
They are also available on DVDs, which can be obtained from our local representatives (contact us).
We would like to thank all speakers and participants who contributed to the great success of the 15th Planova™ Bioprocess Workshop, and we hope the presentation materials provided as above are useful in promoting the global advancement of biopharmaceutical industry.
Holding of the first Planova™ Workshop in India
asahi Kasei Medical Co.，Ltd. is pleased to announce that the first Planova™ Workshop India will take place on January 31, 2013 at the Taj Exotica in Goa.
In India, the biopharmaceutical industry is growing strongly. The development of biosimilars is accelerating at many pharmaceutical companies and Contract Manufacturing Organizations (CMOs). In addition, preparations for the self-production of plasma derivatives are ongoing in India. In these circumstances, the need for virus removal filters is becoming greater and greater.
Planova™ filters were launched in 1989 as the first filters developed specifically for removing viruses from biotherapeutic drugs such as biopharmaceuticals and plasma derivatives. Planova™ filters have two decades of proven safety and reliability in the international biopharmaceuticals industry, including India.
Participation in exhibition/conference in Huntington Beach, California
asahi Kasei Bioprocess, Inc. is pleased to announce its participation in the following exhibition/conference.
Event Name
Biopharmaceutical Development & Production Week
Participation in exhibition/conference in Boston, Massachusetts
asahi Kasei Bioprocess, Inc. is pleased to announce its participation in the following exhibition/conference.
Event Name
PEGS 2013 - essential protein & antibody engineering summit
Participation in exhibition/conference in Boston, Massachusetts
asahi Kasei Bioprocess, Inc. is pleased to announce its participation in the following exhibition/conference.
Event Name
Date
Expansion of our global operations network
In order to expand the coverage of our global technical support and customer service, we are pleased to announce the recent openings of the following customer support offices:
China
asahi Kasei (China) Co., Ltd.
Dublin, Ireland
BioProduction Congress
https://lifesciences.knect365.com/bioproduction/
abstract Only
Cardone, F., et al.
Istituto Superiore di Sanità, CEa/DSV/iMETI/SEPIa and LFB
Strauss, D., et al
asahi Kasei Bioprocess america
Open
Effect of Hydrodynamic Forces on Virus Removal Capability of Planova™ Filters
abstract Only
Yamamoto, a. et al.
asahi Kasei Corporation
abstract Only
Roberts, P. L., et al.
Bio Products Laboratory
abstract Only
Burnouf-Radosevich, M., et al.
Centre Régional de Transfusion Sanguine
Prion removal by nanofiltration under different experimental conditions
abstract Only
Yunoki, M., et al.
Osaka University, Benesis Corporation, Mitsubishi Pharma Corporation, and Invitrogen BioServices
McCue, J., et al
Haemophilia 20(4): e327-e335
Open
The Planova™ Seminar in Beijing
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The Planova™ Seminar in Beijing was held as follows:
March 10th, 2017
The 2nd Planova™ Seminar in Moscow
Learn about Planova™ Workshops and Seminars. Find opportunity to share experiences and to learn the best practices about virus filtration. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
The 2nd Planova™ Seminar in Moscow was held as follows:
September 6th and 7th, 2016
Winge, S., et al.
Octapharma aB
Protein Expression and Purification 115 (2015) 165–175
Kee, S., et al
Biologicals 47: 25–32
Open
Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
McCue, J., et al
Biologicals 43: 213–219
Open
Vienna, austria
TIDES: Europe
https://lifesciences.knect365.com/tides-europe/
Pharmatech & Ingredients
http://www.pharmtech-expo.ru/en-GB/
Moscow, Russia
lmprovements in Down-scaling of Virus Filtration
andreas Wieser,Senior Laboratory associate,Global Pathogen Safety, Baxter BioScience
16th Planova™ Workshop
Rome
Viral safety of C1-inhibitor NF
abstract Only
Terpstra, F. G., et al.
Sanquin Research and Landsteiner Laboratory of the academic Medical Center of the University of amsterdam and Sanquin Plasma Products
abstract Only
Ma, S., et al.
Shandong Taibang Biological Products Co., Ltd. and asahi Kasei Medical Co., Ltd.
abstract Only
Hongo-Hirasaki, T., et al.
asahi Kasei Medical Co., Ltd.
Effect of antibody solution conditions on filter performance for virus removal filter Planova™ 20N
abstract Only
Hongo-Hirasaki, T., et al.
asahi Kasei Medical Co., Ltd.
Removal of small viruses (parvovirus) from IgG solution by virus removal filter Planova™ 20N
abstract Only
Hongo, T., et al.
asahi Kasei Medical Co., Ltd. and Yamaguchi University
The final announcement of the Planova™ Workshop athens, Greece on October, 2015.
We are pleased to release the Final Reminder for the 18th Planova™ Workshop to take place in athens, Greece on the 22nd and 23rd of October 2015. This workshop will feature presentations on the theoretical background and industry-based applications of virus filtration and purification, including process scale-up, with Planova™ and Planova™ BioEX filters, and QyuSpeedTM D and BioOptimal™ MF-SL modules. Distinguished speakers will share their valuable knowledge and experience regarding the use of these products in the development and manufacturing of biologics. Please Contact us to register for the 18th Planova™ Workshop.
We would be honored if you could attend this workshop and be our guest in athens.
5th_announcement_athene.pdf
Participation at BioProcess International Conference & Exposition
BioProcess International Conference & Exposition
Date
Location
Supply of Planova™ Products Unaffected by the Recent Earthquake in Japan
asahi Kasei Medical Co., Ltd. expresses its sincere sympathy to all those affected by the earthquake which occurred on april 14, 2016, in Kumamoto Prefecture of the Kyushu Region of Japan.
We hereby report that this tragic event has had no notable effect on the manufacture and supply of Planova™ filters and related products. an announcement will be made promptly in the event that any effect on the stable supply of Planova™ products is anticipated.
Updated Supply of Planova™ Products Unaffected by the Recent Kumamoto Earthquakes
The Bioprocess Division of asahi Kasei Medical would like to inform our customers that, to the best of our knowledge, the recent series of earthquakes (starting april 14) in Kumamoto Prefecture of the Kyushu Region of Japan has had no significant effect on the production and supply of Planova™ filters and related products, as detailed shown in attached announcement.
If the situation changes significantly, we will naturally do our best to inform you with updated information.
Should you have any enquiries regarding this matter, please contact your local Planova™ representative. Thank you for your understanding and continued support of Planova.
The 2nd Planova™ Seminar in Moscow, Russia
We are pleased to release the First announcement for the 2nd Planova™ Seminar in Moscow. In this seminar, distinguished speakers will make presentations on the most up-to-date virus filtration techniques and the latest trends in the industry.
Featuring
-Simultaneous interpretation in Russian and English will be available for all presentations
The 19th Planova™ Workshop was held in Philadelphia, Pa, USa on September 22 and 23, 2016.
The 19th Planova™ Workshop was held in Philadelphia, Pa, USa on September 22 and 23, 2016. The Workshop was attended by more than 170 speakers and participants, and many fruitful exchanges were had by all who attended. Speakers presented new information and case studies on virus filtration using Planova™ filters. Presentations from 15 speakers were divided into sessions on Fundamental Knowledge, Robustness and Manufacturing and Process Development. The PDFs of presentation slides from the 19th Planova™ Workshop are now available at the Workshop page.
TechniKrom's Bioprocess Operations to be Integrated with asahi Kasei Medical
asahi Kasei Medical and TechniKrom, Inc., a world-leader in the field of bioprocess equipment technology, have concluded an agreement for the transfer of TechniKrom's bioprocess business to asahi Kasei Medical's full ownership. The integration of operations, scheduled for March 1, 2009, will mark a major expansion of asahi Kasei Medical's business, further into the field of bioprocess equipment and separation media.
asahi Kasei Medical's current business in the bioprocess field is centered on Planova™ filters and filtration systems for virus removal in the production of biopharmaceuticals. The integration of TechniKrom's business will enable asahi Kasei Medical to offer a wide range of novel bioprocess separation media, equipment, and systems - advancing technology for the production of high-quality biopharmaceuticals.
Medical-related operations are a focus for strategic expansion under the asahi Kasei Group's Growth action - 2010 management initiative. asahi Kasei Medical's Planova™ virus removal filters are highly regarded by pharmaceuticals manufacturers throughout the world for the outstanding viral safety they enable in bioprocess production, and are relied on in the production processes for a wide range of biotherapeutics.
Integration of Bioprocess Businesses in North america
as part of a strategic program of expansion and development of its worldwide bioprocess business,* asahi Kasei Medical will integrate its US-based Planova™ filter and bioprocess equipment businesses into a single business entity, asahi Kasei Bioprocess, Inc., on January 1, 2010.
Context and objectives of the integration
asahi Kasei Medical manufactures and markets Planova™ hollow-fiber virus removal filters for use in the production of biotherapeutics. Planova™ filters are supplied to North american markets via an import business division of asahi Kasei Medical america Inc. On March 1, 2009, asahi Kasei Medical entered the bioprocess equipment manufacturing business with the acquisition of assets of TechniKrom, Inc. by its US subsidiary asahi Kasei TechniKrom, Inc.
Supply of Planova™ Products Unaffected by the Recent Earthquake in Japan
asahi Kasei Medical Co., Ltd. expresses its sincere sympathy to all those affected by the earthquake which occurred on March 11, 2011, in the Pacific Ocean off the coast of the Tohoku Region of Japan.
We hereby report that this tragic event has had no notable effect on the manufacture and supply of Planova™ filters and related products.
an announcement will be made promptly in the event that any effect on the stable supply of Planova™ products is anticipated.
Change in Division Name of asahi Kasei Medical Co., Ltd.
asahi Kasei Medical Co., Ltd. is pleased to announce that the name of its "Planova™ Division" will be changed to "Bioprocess Division" effective as of april 1, 2011. This division name change reflects the expansion and development of our business beyond virus filtration to other areas of bioprocess consumables and equipment manufacturing business.
Please note that there is no change in our corporate entities and structure, and that our addresses, phone numbers, facsimile numbers and other contact information will remain unchanged.
We look forward to expanding our offering range of purification solutions to the biopharmaceutical industry under our new division name.
availability of presentation materials of the 1st Planova™ Workshop India held in January 2013
We are pleased to announce the availability of presentation materials of the 1st Planova™ Workshop India, which took place in Goa, India on January 31, 2013. The materials can be downloaded from here (please note that login ID and password are required for download).
We would like to thank all speakers and participants who contributed to the great success of the 1st Planova™ Workshop India, and we hope the presentation materials provided as above are useful in promoting the global advancement of biopharmaceutical industry.
availability of the presentation materials of the 16th Planova™ Workshop held in November 2013
We are pleased to announce that the presentation materials of the 16th Planova™ Workshop are now available in this website. The workshop took place in Rome, Italy in November 7 - 8, 2013. The materials can be downloaded here (please note that your login ID and password are necessary for download). The movies of the presentations will be also available and we will announce the availability in due course.
We would like to thank all speakers and participants for their contribution to the great success of the 16th Planova™ Workshop, and we hope that the presentation materials provided above are useful in promoting the global advancement of biopharmaceutical industry.
Participation at BioInnovation Leaders Summit in London, UK
asahi Kasei Bioprocess Europe N.V./S.a. will participate in 7th BioInnovation Leaders Summit, which will be held in London, UK on February 10 - 11. There will be a presentation on QyuSpeedTM D anion Exchange adsorber by Bixente Martirene, Senior Product Manager on February 10. Please see below for further information.
7th European BioInnovation Leaders Summit 2014 London
Date
Receipt of the 60th annual Okochi Memorial Technology Prize
asahi Kasei Medical Co., Ltd. received the 60th annual Okochi Memorial Technology Prize for the development of production technology for virus removal filters and the establishment of a market for them.
The Okochi Memorial Prizes are a prestigious series of prizes with a rich tradition, awarded to honor outstanding achievements in the field of manufacturing engineering and industrial technology in Japan by the Okochi Memorial Foundation in commemoration of Dr. Masatoshi Okochi. This year's award ceremony was held on March 26 at the Industry Club of Japan in Tokyo, Japan.
This prize was awarded in recognition of the contribution to enhanced safety in the manufacture of biotherapeutic products through the establishment of production technology for Planova™ virus removal filters and obtaining their widespread use by manufacturers of plasma derivatives and biopharmaceuticals worldwide. The outstanding performance of Planova™ filters featuring reliable virus clearance, high rates of protein recovery, and effectiveness against various kinds of virus has been widely recognized by manufacturers of biotherapeutics in many countries. It is also expected that the use of Planova™ filters will soon begin in countries and regions where plasma derivatives are not yet manufactured such as China, Southeast asia, India, and South america.
Participation at BioProduction in Barcelona, Spain
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at BioProduction, which will be held in Barcelona, Spain on October 8 - 9. There will be a presentation on Planova™ nanofiltration by Mr. Bixente Martirene on October 8. Please see below for further information.
Date
Location
Participation at BioProcess International 2014 in Boston, Ma, USa
asahi Kasei Bioprocess, Inc. will exhibit at BioProcess International 2014, which will be held in Boston, Ma, USa on October 20-23. There will be the 10 minute presentation on IBDTM 1K Inline Buffer Dilution System. Please see below for further information.
BioProcess International 2014
Date
asahi Chemical Industry Opens New assembly Plant for Planova™ Filters
asahi Chemical Industry today announced the commencement of operations at its new assembly facility for Planova-brand filters in the city of Nobeoka, Miyazaki Prefecture, Japan.
"The viral safety of biologicals remains of paramount importance to manufacturers and health authorities worldwide," said Yasuichiro Yano, General Manager, Planova™ Division, asahi Chemical Industry Co., Ltd. "Filtration with Planova™ filters offers manufacturers yet another means to ensure the viral safety of their biotherapeutic products."
Demand worldwide for Planova™ filters continues to grow as both industry and regulators recognize the merits of incorporating a filtration step to remove viruses during the manufacture of biotechnological and human plasma-derived products.
asahi Chemical Industry to Conduct Planova™ Workshop in Japan in November
asahi Chemical Industry will sponsor Planova™ Workshop 2000 on November 1, 2000, in Tokyo, Japan.
Planova™ Workshops are educational forums for new and experienced users of Planova™ virus removal filters to share the latest information on the practical application of Planova™ filters in manufacturing processes of plasma derivatives and biopharmaceuticals. Each workshop includes a number of speakers from various organizations and companies who have either successfully incorporated Planova™ filtration into their manufacturing processes, or are in the process of conducting evaluation or validation studies of Planova™ filters for their respective therapeutic products.
Representatives from companies and organizations using Planova™ filtration or considering the implementation of Planova™ filtration are encouraged to attend.
asahi Chemical Industry to Market Leak Tester for Planova™ Filters
asahi Chemical Industry today announced the launch of the Planova™ Leak Tester, an automated integrity test unit designed to detect leaks in Planova™ virus removal filters.
an alternative to the manual Leakage Test for Planova™ filters, the pre-programmed tester offers an easy to use operator panel, indicating filter specification conformance.
For further information on the PlanovaLeak Tester, please contact the asahi Chemical Industry office in Tokyo, Japan.
asahi Kasei Corporation (formerly asahi Chemical Industry Co., Ltd.) today introduced the Planova™ 20N filter, designed to retain small non-enveloped viruses, such as parvovirus and hepatitis a virus (HaV), with virus removal factors in excess of 4 logs, while providing high recovery rates for proteins, including plasma-derived immunoglobulin (IgG), Factor VIII, and fibrinogen.
Biotherapeutic product manufacturers and regulatory authorities alike have drawn attention to the limitations of current methods to remove or inactivate non-enveloped viruses across a range of biotherapeutic products with varying molecule sizes and physico-chemical properties. The Planova™ 20N filter removes significant levels of even the smallest of these viruses using size exclusion, irrespective of virus properties.
"The unique structure of the Planova™ 20N membrane enables greater volumes per surface area unit to be effectively cleared of viruses," said Yasuichiro Yano, General Manager, Planova™ Division at asahi Kasei. "This results in a filtration profile unmatched by comparable products currently available on the market."
The training course on virus filtration with PDa in Berlin, Germany
asahi is pleased to announce the conduction of the educative training course on virus filtration on 9th June 2016, organized jointly with PDa Europe in Berlin, Germany.
This training course about virus filtration will provide the attendees with a profound understanding about the current state of the art around this topic. a thorough introduction to virus filtration will be given as well as some in-depth background and a mechanistic understanding about the principles of (parvo-) virus retention will be available to the attendees at the end of the course. an interactive session will address the question of "how to design an efficient virus filtration process?" and a practical session will provide some hands-on experience with lab-scale modules.
PDa Training Course.pdf
Participation in exhibition/conference in Berlin, Germany
asahi Kasei Bioprocess Europe N.V./S.a. is pleased to announce its participation in the following exhibition/conference.
Event Name
PDa Virus & TSE Safety Forum 2013
Participation at Biomanufacturing Summit 2014 in San Diego, Ca, USa
asahi Kasei Bioprocess, Inc. will participate in Biomanufacturing Summit 2014, which will be held in San Diego, California, USa on January 29 - 31.
Biomanufacturing Summit 2014
Date
Participation at BPD 4th annual Single-Use Bioprocess Technologies Symposium in Durham, NC, USa
asahi Kasei Bioprocess, Inc. will participate in BPD 4th annual Single-Use Bioprocess Technologies Symposium, which will be held in San Diego, California, USa on February 13.
BPD 4th annual Single-Use Bioprocess Technologies Symposium
Date
Participation at Interphex 2014 in New York City, NY, USa
asahi Kasei Bioprocess, Inc. will exhibit at Interphex 2014, which will be held in New York City, New York, USa on March 18 - 20.
Date
March 18 - 20, 2014
Participation at Biopharmaceutical Development & Production Week in San Diego, Ca, USa
asahi Kasei Bioprocess, Inc. will exhibit at Biopharmaceutical Development & Production Week, which will be held in San Diego, California, USa on March 24 - 27.
Biopharmaceutical Development & Production Week
Date
asahi Kasei Bioprocess, Inc. will exhibit at the ISPE San Francisco/Bay area Chapter's 23rd annual Vendor Night, which will be held in San Francisco, California, USa on March 27.
ISPE San Francisco/Bay area Chapter 23rd annual Vendor Night
Date
Participation at BioProcess International European Summit in Prague, Czech Republic
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at BioProcess International European Summit, which will be held in Prague, Czech Republic on april 2 - 3. There will be a presentation on aEX chromatography membrane by Stefan Schrankler on april 3. Please see below for further information.
BioProcess International European Summit
Date
Participation at the 21st annual ISPE-CaSa Life Sciences Technology Conference in Raleigh, NC, USa
asahi Kasei Bioprocess, Inc. will exhibit at the 21st annual ISPE-CaSa Life Sciences Technology Conference, which will be held in Raleigh, North Carolina, USa on april 8.
21st annual ISPE-CaSa Life Sciences Technology Conference
Date & Time
Participation at PEGS 2014 in Boston, Ma, USa
asahi Kasei Bioprocess, Inc. will exhibit at PEGS 2014, which will be held in Boston, Massachusetts, USa on May 5 - 6.
Date
May 5 - 6
Participation at TIDES 2014 in Providence, RI, USa
asahi Kasei Bioprocess, Inc. will exhibit at TIDES 2014, which will be held in Providence, Rhode Island, USa on May 12 - 15.
Date
May 12 - 15, 2014
Participation at Interphex Japan in Tokyo, Japan
asahi Kasei Medical Co., Ltd. is pleased to announce its participation in the following exhibition/conference.
Interphex Japan 2014
Date
Participation at The Bioprocessing Summit
asahi Kasei Bioprocess, Inc. will exhibit at The Bioprocessing Summit, which will be held in Boston, Ma, USa on aug 18-22. Please see below for further information.
Date
august 18-22
Participation at ISPE Boston area Chapter annual Product Show in Foxborough, Ma, USa
asahi Kasei Bioprocess, Inc. will exhibit at ISPE Boston area Chapter annual Product Show, which will be held in Foxborough, Ma, USa on Octber 1. Please see below for further information.
ISPE Boston area Chapter annual Product Show
Date
Participation at CPhI worldwide in Paris, France
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at CPhI worldwide, which will be held in Paris, France on October 7 - 9. Please see below for further information.
Date
Location
Participation at Biotalk in Berlin, Germany
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at Biotalk in Berlin, Germany on September 25-26. There will be a presentation on Virus Filtration by Sebastian Teitz on September 26. Please see below for further information.
BioTalk
Date
Participation at EuroTIDES 2014 in Berlin, Germany
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at EuroTIDES 2014 in Berlin, Germany on November 18-19. Please see below for further information.
Date
Location
Participation at Pharmtech 2014 in Moscow, Russia
asahi Kasei Bioprocess Europe N.V./S.a. will exhibit at Pharmtech 2014 in Moscow, Russia on November 25-28. Please see below for further information.
Pharmtech 2014
Date
Participation at 28th Interphex Japan in Tokyo, Japan
We will exhibit at 28th Interphex Japan in Tokyo, Japan on July 1-3, 2015. Please see below for further information.
28th Interphex Japan
Date
Participation at aCHEMa 2015 in Frankfurt, Germany
We will exhibit at aCHEMa 2015 in Frankfurt, Germany on June 15 - 19, 2015. Please see below for further information.
aCHEMa 2015
Date
Participation at The Bioprocessing Summit in Boston, Ma on august 3 - 7, 2015
We will exhibit at The Bioprocessing Summit in Boston, Ma on august 3 - 7, 2015. Please see below for further information.
Date
august 3 - 7, 2015
Date
Location
Berlin, Germany
Effective virus inactivation and removal by steps of Biotest Pharmaceuticals IGIV production process
Dichtelmuller H. O., et al.
Biotest aG and Biotest Pharmaceuticals
Open
Virus filtration of high-concentration monoclonal antibody solutions
abstract Only
Marques, B., et al.
Merck and Co., Inc.
Garger, S., et al
Bayer
Haemophilia 23(2): e67-e78
No abstract
Maerz, H., et al.
University of Leipzig, Humboldt-University/Charite, Dr. Fooke Laboratorien GmbH, and asahi Chemical Industries
Phage passage after extended processing in small-virus-retentive filters
abstract Only
Lute, S., et al.
Food and Drug administration and Eli Lilly and Company
Large-scale production and properties of human plasma-derived activated Factor VII concentrate
abstract Only
Tomokiyo, K., et al.
Kaketsuken
In vitro study of a triple-secured von Willebrand factor concentrate
abstract Only
Mazurier, C., et al.
Laboratoire Francais du Franctionnement et des Biotechnologies
Implementation of a 20-nm pore-size filter in the plasma-derived Factor VIII manufacturing process
abstract Only
Furuya, K., et al.
Japanese Red Cross Plasma Fractionation Center
abstract Only
Kreil, T., et al.
Baxter BioScience
abstract Only
Poelsler, G., et al.
Baxter Bioscience